Category Archives: Stocks to Watch

ContraVir Pharmaceuticals, Inc. (CTRV) Set to Shake Up HBV Therapy Market with Combination Therapy Based on CMX157 & CRV431

October 20, 2016

A constant theme that comes up in and often dominates the leading edge of the biopharma sector is the building of better mousetraps. This is certainly the case for New Jersey-based biopharma developer ContraVir Pharmaceuticals (NASDAQ: CTRV), whose phase 2a clinical antiviral candidate CMX157 ( is knocking loudly on the door of Gilead Sciences’ (NASDAQ: GILD) Viread® (TDF, or tenofovir disoproxil fumarate) in chronic hepatitis B virus (HBV).

Coming out of the box strong after notably successful phase 1 safety and efficacy trials, ContraVir was quite proud to recently announce ( that the ongoing head-to-head phase 2a (multiple ascending dose) clinical study of its highly potent prodrug of tenofovir (TFV), CMX157, is showing serious potential versus Viread. With data points like a 99 percent reduction in viral load ( among patients orally dosed with 25 mg of CMX157, compared to a 300 mg TDF dose, the company is obviously excited about CMX157’s ability to deliver significant viral load reduction safely, at a much lower dose. Delimiting systemic/liver toxicity issues has long been the industry brass ring, and it now looks like that goal is considerably within CTRV’s striking distance.

ContraVir sees CMX157 as the backbone of a rapidly emerging combination therapy approach to HBV, where the liver-targeting capabilities of its prodrug candidate help to reduce impact to other tissue systems. There are a list of significant potential advantages for CMX157 over something like Viread at the point of sale, and ContraVir is bucking hard to not only cure HBV, but slice off an ever larger piece of the global HBV therapeutics market, a market that is on track to do a modest 2.4% CAGR through 2024, when it will reach upwards of $3 billion ( The enhanced bioavailability of CMX157’s novel structure compared to existing indications (which also helps deal with liver damage by reducing the indication’s overall circulatory footprint), is now starting to really come to light through the latest clinical results.

Early on, when the company began touting CMX157’s ability to exploit natural lipid uptake mechanisms, and how this candidate showed in vitro HBV aggression 97 times greater than TFV during its phase 1 days, investors should’ve been paying closer attention. The data from this latest clinical work is consistent with extant data stretching back to preclinical work on CMX157, and with around 786,000 people dying worldwide each year ( (mostly due to HBV-related liver disease like cirrhosis and liver cancer) from HBV, ContraVir’s work has become a hot topic. CMX157 has previously been found to be well tolerated at dosages up to 100 mg, so the fact that this stuff is basically doing Viread numbers at 25 mg already spells big things for the ongoing dose escalation work being conducted by CTRV.

CMX157 is just the tip of the proverbial iceberg that is ContraVir’s growing pipeline of candidates, a pipeline which includes an impressive next-gen cyclophilin inhibitor with enhanced potency and selectivity, known as CRV431 ( With IND-enabling study work in the offing and a target sometime next year for CRV431 clinical trials, CTRV is really shaping up to be one of the leading alternative HBV therapy developers. CRV431’s ability to attack the life cycle of HBV at numerous points along the arc is a key advantage, and that combination therapy strategy the company keeps pushing really starts to make sense when you take a closer look at the potential advantages of CRV431.

These advantages include a sharp reduction in HBV DNA (in vivo), without toxicity, meaning that liver fibrosis can be hugely downgraded as a complication. Pair that up with a demonstrated ability to actually block entry for HBV into liver cells, and it is little wonder that ContraVir is looking to the horizon for a combination approach with CMX157 as the situation commander, and ancillary indications like best-in-class potency CRV431 on street-sweeper detail. Talk about laying down cover fire: CRV431 is anticipated to be effective against all HBV genotypes, offers broad-spectrum blockage of a large portion of specific HBV protein interaction with host cell cyclophilins, and provides a clearly complementary method of action for CMX157.

In short, the company has both the vision and the technology to deliver on a promise to HBV patients that first became apparent with the emergence of what is now basically a lifetime cure for hepatitis C. The HBV field has been driving hard toward this goal, inspired by what has been done in hepatitis C, and it now appears that New Jersey’s own CTRV could be the one to run this ball into the end zone. Moreover, it was very encouraging to investors to see how the New Jersey Economic Development Authority’s highly competitive Technology Business Tax Certificate Transfer Program (which allows New Jersey-based companies to sell R&D tax credits or net operating losses for up to 80 percent of value), provided $1.8 million in non-dilutive funding ( for CTRV, which has been instrumental for this homegrown biopharma success story to put the pedal to the metal on its HBV pipeline.

Hepatitis B is most prevalent in the regions of sub-Saharan Africa and East Asia, where as much as 10 percent of the population in certain areas is chronically infected. Globally, the number of infected ranges upwards of the CDC/WHO official figure of 240 million, and with as many as 2.2 million chronic hepatitis B cases in the U.S. alone, CTRV’s technology could mean that the company is sitting on a potential goldmine, a goldmine that could provide a beacon of hope for millions.

The broader therapeutics market for liver diseases was around $7.5 billion in 2014, and a recent report published by Grand View Research sees the antiviral segment as the most promising, with 8.9 percent growth anticipated through 2022 ( The overall liver disease therapy market is on track to surpass $12 billion during that same interval, with the Asia Pacific region expected to do a CAGR similar to the antiviral segment, running around 8.8 percent. There is a huge external market for CTRV, and the possibilities of pipeline commercialization are indeed tantalizing.

Many investors are already talking about how instrumental the addition of biotech veteran Thomas H. Adams, Ph.D., to the CTRV Board back in September has been with regard to all of this, by the way. After all, this is the guy who founded antisense biotech innovator Genta, as well as Gen-Probe, which was acquired by the same Chugai Pharmaceutical ( that later ended up in a strategic alliance with biopharma juggernaut Roche (OTC: RHHBY). Even without addressing the company’s pivotal phase 3 trial of its FV-100 indication, engineered to reduce incident rates and severity of shingles (herpes zoster), as well as the severe post-herpetic neuralgia (PHN) pain associated with shingles – CTRV is the kind of near-commercialization contender that many biopharma investors dream of.

The market for FV-100 shows a lot of upside potential, in particular, due to a rapidly accumulating adult population across developed countries. In the U.S., the number of persons 65 years and older is projected to go from just 14.5 percent of the overall population two years ago, to 21.7 percent or more of total population by 2040 ( FV-100 has demonstrated safety and efficacy with clinically meaningful reduction in PHN rates versus GlaxoSmithKline’s (NYSE: GSK) Valtrex® (valacyclovir).

With as much as 10 percent fewer of 350 patients treated with FV-100 requiring some form of narcotics for pain control, this fast-acting, low-dose, once-daily, oral antiviral could really become one of CTRV’s money makers. PHN is the most common/clinically relevant complication with shingles, and FV-100’s pivotal phase 3 trial could spell much needed relief, especially for elderly patients who already have trouble sleeping, or who suffer from other quality of life-diminishing problems associated with shingles.

There is a lot to like about ContraVir, take a closer look by visiting

Stealth Technologies (STTH) Products Highly Effective against RFID Skimming, Personal Data Theft

October 17, 2016

Radio-frequency identification (RFID) technology is on the rise, having multiple applications in various industries ranging from healthcare and storage to transport, animal and human identification, as well as for RFID-empowered credit cards. The technology allows for a much simpler card payment process by enabling the user to simply brush his or her card against a special RFID reader to process a payment, but it has also given rise to serious privacy concerns and fears that personal information is easier to steal by anyone with the right type of RFID reading equipment. As a consequence, tighter security requirements were enforced for manufacturers of RFID tag technology, while special equipment emerged, designed to shield against RFID skimming and hackers.

A leading provider of personal security production and data protection technology, Florida-based Stealth Technologies, Inc. (OTCQB: STTH), comes to the aid of all owners of RFID-enabled cards with proprietary technology specifically created to protect the consumer’s data from any theft attempts or other compromising events. The company’s flagship product, the Stealth Card, can actively protect users’ RFID cards in their wallets by creating an electromagnetic force field that blocks any scan attempts and deflects the scans back to their source. Inspired by military technology employed to shield stealth aircraft from radar, the Stealth Card uses a proprietary PowerGrid Technology that blocks any inbound or outbound frequencies and effectively makes a card’s RFID chip invisible to theft threats.

At only 0.007” thick, the Stealth Card easily fits in the wallet and can protect up to 12 RFID cards simultaneously, as confirmed during tests run by The Center for Applied Research and Technology, an independent testing laboratory. The product does not require batteries or charging and works perfectly with cellphones, magnetic strips or Bluetooth technology without interference.

Encouraged by the success of the Stealth Card and facing a growing demand for RFID skimming blocking solutions on a market that’s expected to surpass $21 billion by 2020, Stealth Technologies has developed two other products designed to help protect users’ personal information: 911 Help Now and Stealth Mobile.

Rolled out in July of this year, the 911 Help Now device offers direct voice communication with emergency services with the simple push of a button. A compact, waterproof design powered by standard AAA batteries, the device works as a 24-hour emergency system that can be carried around anywhere, offering the user peace of mind in any and all environments.

Stealth Mobile has yet to be launched after having successfully passed the final testing phase of development at the end of September, according to company CEO Brian McFadden. The product is designed to protect the Near Field Communication (NFC) chip and any personal and financial information stored on the user’s cell phone. It can be easily attached to the back of the phone and will protect the user’s data by blocking any theft attempts via the NFC system.

In another effort to combat identity theft, the company recently launched a dedicated website,, which offers visitors access to ‘Data Secure,’ a unique personal identity theft protection and recovery service designed and used by law enforcement. The service uses a two-step prevention method: the Redaction/Privacy process that removes personal data from the Internet, and the Recovery Protection process that involves recovery specialists working to restore a stolen identity.

For more information about Stealth Technologies, Inc. and its innovative personal data protection services, visit

Tip and be Tipped; Fosters Trader Interaction

October 14, 2016

DTG, a consortium of unique marketing brands that utilizes one dynamic approach to connect publicly traded companies with a variety of investors, recently unveiled its newest platform, www.Tip.Us, a site dedicated to keeping the investment community abreast on “who’s who” among small-cap stocks. puts a twist on “hot stock ideas” by promoting the involvement of stock traders themselves to fuel a dynamic network of informed investors.

When someone knows of a stock ready to make a run, they can tip us off via online submission (

Those looking for trading ideas should head over to the Tip of the Day to see which stocks other traders are watching and why. This page provides stock activity, recent news, and company information on each presented stock.

The brand also features the Tip of the Week newsletter, where subscribers are alerted to one stock with a lot of hype, along with a number of other stocks to keep on radar. To sign up for this free weekly feature, visit

“We are excited to offer to promote cross-communication and interactivity among active traders,” stated Michael McCarthy, Managing Director of DTG. “Utilizing our newest platform, traders can get notified of small-cap stocks making waves before the big break while feeding us stock tips we can relay to other users. Working together, we aim to form an active, collective pool of small-cap stocks earning warranted attention.”

Let us hear your thoughts below:

Issuer Direct Corp. (ISDR) Increasingly Prominent One-Stop-Shop for Targeted PR/IR Engagement, Cloud-Based Compliance, Disclosure Solutions

September 30, 2016

As one of the leading pioneers in the world of secure, cloud-driven regulatory compliance, as well as investor communication solutions, Issuer Direct (NYSE MKT: ISDR) is currently the go-to Disclosure Management System (DMS) source for thousands of compliance issuers around the world, as well as for hundreds of corporate issuers, which derive substantial advantages from the company’s affordable, but extremely robust suite of branded solutions.

Issuer Direct’s already widely successful toolset stands to remain at the head of the pack alongside players like Certent, which was recently selected by PR Newswire to augment its own flexible XBRL tagging and filing solution with Certent’s own DM tech. Compliance looks to be one of the hottest, fastest-growing segments of the $3 billion and growing legal technology solutions market ( There is plenty of room here for an agile, cost-competitive player with advanced technology and a mountain of in-house experience like ISDR, even with bigger sharks like IBM (NYSE: IBM) and SAP (NYSE: SAP) circling the market.

The same kind of rock-solid value brought to the table with ISDR’s proprietary cloud-based DMS framework, so noteworthy for its security, performance and ease of use, is also present in the company’s other offerings, whether we are talking about Issuer Direct’s premier regional, national and global news/communications network, Accesswire®; the company’s extremely robust media, advisor and investor targeting dataset platform, Classify®; or ISDR’s SEC filing marvel, known as Blueprint®.

Accesswire is particularly interesting given that the platform was designed from the ground up specifically for public companies, as well as due to the sheer scale of Accesswire’s end-user footprint and the ease with which public companies can join the Accesswire News Network before almost immediately using it to disseminate messages to that huge audience in real-time. Underlying this supremely attractive megaphone functionality is a powerful analytics engine that exposes information like actual social engagement metrics of a given release, as well as the subsequent/relevant audience targeting solutions, via a highly intuitive dashboard. Putting the power into users’ hands, allowing them to really understand what works (or just how well whatever they are doing is working), ensures confidence in PR budgets and makes the platform an easy sell to public companies who are hungry to engage the investment community.

Because ISDR so intimately understands the regulatory environment, the announcements that need to go to SEDAR or EDGAR are always routed. Accesswire is partnered with the top names in business media today, such as Reuters (NYSE:TRI), The Wall Street Journal (NASDAQ: NWSA) and The New York Times (NYSE: NYT), as well as Stock Exchanges, local newspapers of record, The Associated Press and United Press International, and digital data feeders like Yahoo! Finance (NASDAQ: YHOO) – to name but a few.

Little wonder then that ISDR was recently able to report Q2 revenue growth from its Accesswire press release business of 18 percent (compared to Q1), which was up a handsome 73 percent year-over-year ( Accompanied by a 74 percent gross margin for the quarter and an additional $1 million in operational cash flow, the quarterly dividend increase issued back in July on the strength of continued positive earnings and cash flow has substantially encouraged ISDR shareholders to remain bullish about the company’s prospects. Accesswire’s distribution channels line up superbly with the company’s investor network and investor calendar, as well as ISDR’s public company outreach platform, providing unparalleled venue reach that includes the Dow Jones Network and the Factiva system, as well as top broker-dealers. Needless to say, this is a winning proposition to public companies, and business has been very good for Issuer Direct.

In fact, revenues from platform and technology solutions were up 20 percent last quarter when compared to Q1, with both Blueprint and Classify showing marked traction. Even as the traditional Annual Report Service (ARS) business flags amid an ongoing shift to digital over hardcopy, and market commoditization hammers XBRL demand, Issuer Direct has actually prospered. Intelligent restructuring of channel partner agreements in its ARS game, as well as receptivity to the company’s innovative cloud-based offerings, have allowed ISDR to soar where lesser operators may have folded altogether.

Blueprint deserves a closer look here, for instance, due not only to a recent partnership expansion with the London Stock Exchange Group that includes the SEC reporting platform’s license to LSEG’s RNS (regulatory news service), but because the LSEG deal is just the latest example of end-market resonance for Issuer Direct. LSEG’s RNS wanted a way to automate the reformatting of their own systemically generated HTML into SEC EDGAR-compliant documentation, and the readily adaptable Blueprint platform was perfect for the job – a deal which has crystallized an already tight-knit relationship between LSEG and ISDR. Issuer Direct’s CEO, Balbirnie, was keen to point out the number of high profile clients that have already signed on with Blueprint as a hallmark of the platform’s inherent value. The top dog at LSEG/RNS roundly affirmed this conclusion, while also pointing to Blueprint’s scalability as leaving the door open to a host of future applications.

That scalability is a big sell for Blueprint, alongside the platform’s baseline cost-effectiveness and ease of use, as it allows great confidence that ISDR can fulfill the role of trusted regulatory platform provider for years to come (no matter how big or small the client). The ability to handle essentially any document type via a proprietary compliance editing platform like Blueprint, which alleviates the historically time-consuming and cumbersome process of regulatory filing, when combined with the company’s DMS platform, makes for a super-fast, real-time project creation/editing workflow that has to be experienced to be believed. The ironclad value of the company’s DMS platform, engineered to meet and keep up with the ever more stringent demands of regulatory authorities like the SEC, DTCC and FINRA, is further enhanced by dynamic shareholder communication features.

Issuer Direct even offers naturally parallel services such as stock transfer agent and proxy services, as well as full-spectrum document design, formatting and typesetting – the company even does printing/fulfillment with real-time tracking. Transfer agent duties come second nature to an outfit like Issuer Direct, and with the in-house talent to easily handle everything from electronic stock issuance and management, to document preparation and review, ISDR is increasingly seen as a one-stop-shop for a variety of such services.

For more information, visit

Lifeloc Technologies, Inc. (LCTC) Products Crucial for Combating Occupational Alcoholism, Drug Use

September 29, 2016

Occupational alcoholism and drug use are serious problems among America’s workforce, leading to major expenses and issues ranging from low employee morale and absenteeism to lost productivity, theft, injuries and even fatalities. Costs associated with alcohol abuse in the workplace alone range anywhere between $33 billion and $68 billion per year, studies show. Faced with this problem, a growing number of businesses are introducing mandatory workplace drug and alcohol testing by enrolling the help of industry leader Lifeloc Technologies, Inc. (OTC: LCTC).

Of the approximately 142.63 million people employed in the U.S. as of September 2015, about 14 million are alcoholics. A factsheet from the National Council on Alcoholism and Drug Dependence ( shows that roughly 6.6 percent of full-time employees are frequent and heavy drinkers, having had five or more drinks at once during more than five occasions within the last 30 days. Of current adult illegal drug users aged 18 to 49, 70% are employed full-time, the NCADD data also shows.

Alcohol and drug abuse can be a major financial burden for employees and businesses, both in terms of higher health care costs, workers’ compensation and legal liabilities, as well as in lost productivity, absenteeism, injuries on the job, fatal accidents and more. Additional problems may include tardiness and sleeping on the job, poor decision making, loss of efficiency, reduced job performance and even having trouble with co-workers or supervisors. Some of the jobs ad industries with increased occupational alcoholism rates and alcohol-related deaths include bartenders, shoe machine operators, roofers, painters, cooks, sailors and construction workers.

According to NCADD statistics, alcohol and drug testing as part of the hiring process remains the most common method used by employers to identify candidates with a substance abuse problem. Only about one quarter of workers interviewed reported random testing on the job, while 30% mentioned testing upon suspicion and 29% mentioned testing after an incident.

Lifeloc Technologies comes to the aid of all businesses and industries with a wide range of DOT and NHTSA approved, high-precision alcohol and drug testing solutions, whether for pre-employment, random, post-accident, return-to-duty or stand-down testing. With more than 30 years of experience in the industry, the company offers complete alcohol and drug testing solutions, including handheld breath testing instruments for screening and confirmation, as well as training, supplies and consultations to guide customers through all aspects of setting up alcohol and drug testing programs in the workplace. Two of Lifeloc’s most popular products for workplace alcohol testing, the Phoenix 6.0 Bluetooth and the EV30, are based on proprietary technology and are guaranteed to give accurate and reliable readings.

A global leader in the breath alcohol testing industry, Lifeloc offers a complete range of evidential breath testers and portable breath alcohol testers to markets such as law enforcement, schools, corrections, and workplace. Its products are also recognized and distributed internationally through a complex global network of specialists that also offer consultation, support and service.

For more information, visit

EquityFeed Revolutionizes Stock Hunting

If you’re an active trader, chances are you sip through a couple cups of coffee before you’re finishing checking on your stocks and scouring the market for high-potential plays. Making the rounds is a several-times-a-day routine, but is it a simple and effective one?

EquityFeed is a new platform designed specifically for active traders and day traders who want to fully utilize their time and maximize profits. The platform offers a sweeping set of easy-to-use features, many of which are customizable to each user’s unique preferences.

Stock screening capabilities are powered by EquityFeed’s Filter Builder, an ideal tool for intraday trading. The system allows the trader to select various analytics and view immediate results based on chosen criterion. The way EquityFeed states it, using the platform’s filtering system makes hunting for stocks “like shooting fish in a barrel.”

EquityFeed’s pattern recognition tool alerts traders to pertinent and profitable technical events like new highs and lows, volume and price breakouts, and block trades – all in real-time.

Users also have access to one of the industry’s fastest and most advanced news streamers, also loaded with powerful filtering features. This is real-time news at its finest. EquityFeed’s MarketView displays entire equity markets ranked and sorted according to user preference allowing for easy viewing of active stocks.

When you’re ready for more in-depth monitoring, EquityFeed’s Chart Montage is the way to go. After an interesting stock has been identified, the Chart Montage delivers real-time Level 1 data of the play’s technical indicators. It doesn’t stop there; EquityFeed’s Level 2 quotes display shows any stock’s order book with all the market makers who are lined up on bid and ask prices. It’s a play-by-play display of Level 2 action.

These are just several features within the EquityFeed platform. If you’re ready to spend less time while making more, sign up for a free 14-day trial to get started.

Visit for more information.

Stay Informed with the QualityStocks Blog!

September 23, 2016

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

One of our most popular ways, the QualityStocks Blog, keeps investors up to date on everything related to the Small-Cap and Micro-Cap markets. Alternative fuels and power sources, entertainment media, telecommunications, delivery services, healthcare, and retail are all covered on a regular basis. By visiting our blog, investors discover emerging companies that they otherwise would not have heard about.

To view our blog, visit:

If you would like to subscribe via an RSS reader, here’s our feed URL:

Let us hear your thoughts below:

EnteroMedics, Inc. (ETRM) is Pulling its Weight in the Fight Against Obesity

EnteroMedics, Inc. (NASDAQ: ETRM) aims to make America leaner and fitter. The company, based in St. Paul, Minnesota, provides safe, reliable and effective products and therapies to treat obesity and metabolic disorders. Its signature technology, the vBloc® vagal blocking therapy delivered via the Maestro® Rechargeable System, is gaining increasing acceptance both domestically and abroad. vBloc® offers the overweight and the obese relief from those extra pounds that, all too often, trigger a variety of problematic medical conditions.

Overweight and obesity are global problems, but America appears to have taken the cake. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), an agency of the U.S. Department of Health and Human Services, has published statistics that are quite alarming. ‘More than 2 in 3 adults are considered to be overweight or obese’ and ‘more than 1 in 3 adults are considered to be obese’.

Overweight is excess body weight due to too much muscle, bone, fat or water. Obesity is an excess amount of body fat. One measure of overweight and obesity is the Body Mass Index (BMI), which is a person’s weight (in kilograms) divided by the square of his or her height (in meters). Your weight is considered normal if the BMI is under 25. Anyone with a BMI over 25 and under 30 is considered overweight. If your BMI is 30 or over, you are obese.

Extra weight means extra stress for the vital organs. The liver, heart, kidneys and pancreas are all adversely affected by visceral fat, the internal fatty tissue that develops to enfold them. Unlike the benign deposits of fat that lie just beneath the skin, which shape our figures, visceral fat is highly toxic. ‘Visceral fat has been linked to metabolic disturbances and increased risk for cardiovascular disease and type 2 diabetes. In women, it is also associated with breast cancer and the need for gallbladder surgery’, according to this ( Harvard Medical School publication. The NIDDK lists the health risks of overweight and obesity as type 2 diabetes, heart disease, high blood pressure, nonalcoholic fatty liver disorders, osteoarthritis, stroke and cancers of the breast, colon, uterine lining and kidney.

Chronic cases of overweight and obesity are treated by surgery. American Society for Metabolic and Bariatric Surgery (ASMBS) figures, as reported by News Medical (, relate that ‘about 193,000 people had bariatric surgery in 2014… sleeve gastrectomy was… found to be the most common procedure, accounting for 51.7 percent of weight-loss operations, followed by gastric bypass (26.8%), gastric band (9.5%), and biliopancreatic diversion with duodenal switch (0.4%).’ These are all intensely intrusive procedures with many risks that may be hard to stomach. Sleeve gastrectomy, for example, is a procedure in which up to 80 percent of the stomach can be removed.

The vBloc® vagal blocking therapy from EnteroMedics, Inc. is, on the other hand, minimally invasive. It is implanted under the skin just outside the ribcage and involves limited scarring. Recovery time from surgery is short. Some patients reported having the surgery on Friday and going out to work the following Monday.

The vBloc® Therapy works to control sensations of hunger using a pacemaker-like device. A Briefing Document ( on the FDA website indicates that when the therapy is used for 12 hours per day as prescribed, patients experienced an average excess weight loss of 28 percent over one year. This was 50 percent more weight loss than patients who did not receive vBloc®.

In June 2016, EnteroMedics announced a series of successful vBloc procedures at the Beltline Bariatric and Surgical Group in Atlanta, Georgia. And this week, it was disclosed that the European Patent Office had issued a Notice of Intention to Grant a European Patent covering safety features of the Company’s vBloc® Neurometabolic Therapy System. EnteroMedics, with its vBloc® Therapy, is beginning to look like a heavy hitter.

For more information, please visit

Net Element, Inc. (NETE) Records Strong Transaction Volume Growth through First Seven Months of 2016

September 20, 2016

Earlier today, Net Element, Inc. (NASDAQ: NETE) announced its transaction processing volume for the first seven months of 2016, as compared to the same period from a year ago. Notably, the company recorded a 77 percent year-over-year increase in total dollars processed (discounting the effects of foreign currency exchange) to $1,025.8 million for the period. A significant portion of this rise was attributed to Net Element’s online solutions, which saw an increase of 90 percent from 2015 to $305 million. Likewise, volume from mobile solutions rose 84 percent to $23.4 million. Oleg Firer, chief executive officer of Net Element, commented on the strong performance in this morning’s news release.

“We are pleased with our continued growth and further penetration into emerging markets,” he stated. “Our growth is facilitated by our innovative, customer-focused products and services and delivered by teams of outstanding people. We are hopeful that this trend will continue for the remainder of 2016 and beyond.”

The company achieved similar growth in total transactions processed, reporting an increase of 32 percent to 99 million for the seven month period. A large percentage of Net Element’s increase in transactions occurred in North America, where the company recorded a 67 percent spike from 26.7 million in the first seven months of 2015 to 44.5 million this year. Among this growth, online solution experienced a 27 percent increase, while mobile solutions processed a seven percent increase. Net Element notes that the majority of this growth across all segments was organic.

Net Element’s success in expanding its transaction processing volume during the first seven months of 2016 is bolstered by the company’s recent updates regarding future growth. Earlier this month, the company announced that its subsidiary, PayOnline, recently opened an office in Kazakhstan in order to continue expanding its presence in Central Asia. This decision followed the opening of a PayOnline sales office in Yekaterinburg, Russia, earlier this year. In 2015, the company’s electronic commerce volume in Kazakhstan eclipsed $11 billion. When considering that electronic commerce currently accounts for just one percent of total commerce in Kazakhstan, Net Element’s presence in the country represents an incredible opportunity for future growth.

With this strong transaction volume growth and a lengthy runway for continued expansion, it came as little surprise when, earlier this month, Net Element was named one of the South Florida Business Journal’s ‘Top 25 Fastest-Growing Technology Companies’. Inclusion on this list, which recognizes companies based on percentage growth over a two-year time frame, includes special coverage in an upcoming edition of the South Florida Business Journal.

For more information, visit

EquityFeed for Newbies and Market Pros Alike

September 16, 2016

Whether you’re a rookie or veteran trader you can’t afford to cut corners; you need access to who is moving in the market and what’s behind the move. A profitable portfolio relies on customizable, real-time, highly accurate data that answers both. EquityFeed has emerged as the premier real-time platform designed to help individual traders of all levels stay informed and maximize their plays.

Hundreds of otherwise unknown stocks drive significant profits each day. EquityFeed’s affordable, pay-as-you-go platform helps traders find these movers by providing access to charts, technical, watchlists, custom filters and newsfeeds, and more.

There’s endless money to be made in U.S. equities – OTC, AMEX, NYSE, NASDAQ – and whatever your preference, EquityFeed has you covered. Traders can choose from two bundles. Each package comes with a suite of features including Level 2 quotes, watchlists, chart montage, personal alerts, trading alerts, customized filters, stock scanner, real-time news streamer, personal trading coach and more.

With EquityFeed there’s never such thing as not enough information.

For more information visit

Net Element, Inc. (NETE) Shares Surge following Prestigious Industry Recognition

September 15, 2016

Shares of Net Element climbed as much as 47% in Wednesday’s mid-day trade, a day after the payment processing innovator announced its inclusion to South Florida Business Journal’s Top 25 Fastest-Growing Technology Companies.

Net Element CEO Oleg Firer attributes the recognition to the company’s pattern of sustainable growth, as well as the diligence of corporate staff as the company moves toward deeper traction in its chosen markets.

“We are honored to be recognized for our consistent and strong growth,” Oleg Firer, CEO of Net Element stated in the news release. “This recognition is a testament to the hard work and dedication of the entire Net Element team as we continue to focus on powering global commerce and bringing disruptive technologies to our customers.”

The South Florida Business Journal selects companies for its annual list based on percentage growth over a two-year period. Each company honored with the 2016 Technology Award will be recognized at a formal event taking place October 13, 2016. The companies will also be listed in a special section of the Business Journal that will include coverage of the 2016 Technology Awards. For more information, visit

Net Element is a global technology company delivering electronic payment solutions that enable merchants to process transactions through various integrated platforms. The company provides its services through a portfolio of operating companies with disruptive technologies in their respective fields. By tapping into large, relatively underserved markets, Net Element has a track record of impressive year-over-year growth, and continues to secure leading positions in select markets.

For more information, visit

Palatin Technologies (PTN) Continues the Sexual Revolution

September 12, 2016

It will soon be 50 years since the publication of Dr. David Reuben’s Everything You Always Wanted to Know about Sex: But Were Afraid to Ask had its profoundly liberalizing effect on our attitudes toward sex. The best seller helped bring the discussion on sexual behavior out of the bedroom and into other, more public forums. Its timing was opportune. In 1969, when it made its first appearance, America was already in the throes of a ‘sexual revolution’.

Reuben’s opus aligned with the emerging anti-Puritanical thinking that sexual desire was not something to be ashamed of. However, despite raising awareness that the desire for sexual satisfaction is acceptable, his manual was, unfortunately, silent on the pathologies that may plague sexual activity. Now it’s left to biopharmaceutical companies like Palatin Technologies, Inc. (NYSE MKT: PTN) to advance the ‘sexual revolution’.

Palatin Technologies has been doing just that for 20 years, ever since it started its biopharmaceutical operations in 1996. The company is focused on developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Its lead product is Bremelanotide, which it is developing for the treatment of female sexual dysfunction (FSD). Bremelanotide is currently undergoing phase III clinical trials for a type of FSD known as hypoactive sexual desire disorder (HSDD) in pre-menopausal women. The essential feature of female HSDD is a deficiency or absence of sexual fantasies and desire for sexual activity resulting in marked distress and/or interpersonal difficulty.

The prevalence of HSDD is extensive. A publication in Sexual Medicine Reviews ( states that ‘HSDD is present in 8.9% of women ages 18 to 44, 12.3% ages 45 to 64, and 7.4% over 65.’ Other estimates ( put its occurrence at up to ‘one-third of adult women in the U.S.’ And a groundbreaking paper of 2011 on female HSDD ( claimed ‘lack of sexual desire or interest in sexual activity affects up to 43% of the adult American female population’ going on to say that ‘hypoactive sexual desire disorder (HSDD) is considered the most prevalent sexual disorder in women, and one of the most challenging to overcome.’

If even the most modest appraisals of HSDD’s extent are considered, it is apparent that the condition is an unmet medical need that presents a multi-billion dollar market opportunity. The last Census Bureau (2010) figures indicate that there are some 60 million pre-menopausal women in the U.S. Consequently, the potential market for Bremelanotide could be at least six million and may be as high as 24 million. Palatin estimates a market size of eight million with anticipated sales of $1.3 billion by 2020.

Palatin has already completed enrolling patients in two North American phase III pivotal trials for Bremelanotide. All patient visits in these phase III pivotal trials have been completed and top-line results are expected late in the third quarter of 2016. The company expects to file a New Drug Application (NDA) for Bremelanotide in the first half of 2017.

Palatin has other promising drugs in its pipeline. PL-3994 is a candidate for improving treatment outcomes in heart failure. Two phase I studies have already been completed for PL-3994 and a phase II trial is at the point of starting. For treatment of a variety of inflammatory diseases, the company is working on a melanocortin receptor-1 (MC1r) peptide drug. MC1r may have application in the treatment of inflammatory bowel disease, nephritis (inflammation of the kidneys), rheumatoid arthritis, and certain ocular and dermatologic indications. In addition, a melanocortin receptor-4 (MC4r) peptide candidate has had clinical proof-of-principle established. Proof-of-principle studies are an early stage of clinical drug development when a compound has shown potential in animal models and early safety testing.

For more information, visit

GTX Corp. (GTXO) Reports 133% YOY Increase in Subscriber Revenue as Wearable Tech Market Matures

August 29, 2016

The consumer market for wearable technology is in a period of rapid growth. According to Statista (, sales of wearables exceeded $2 billion in 2015, and forecasts call for sales of more than $4 billion in 2017. This growth is, of course, being led by some heavy hitters in the tech industry. Apple (NASDAQ: AAPL) launched its Apple Watch to much fanfare in April 2015, and, according to Juniper Research (, the company had successfully secured 52 percent market share in the burgeoning smartwatch space by the end of that calendar year. In recent months, however, sales have begun to slow. According to a report from market research firm IDC, Apple Watch sales have already dropped 55 percent since the product’s launch, likely due to anticipated hardware updates in the coming months.

Apple is far from alone in its efforts to bring innovation to the wearable technology space. Google (NASDAQ: GOOG; GOOGL) also entered the market with its innovative Google Glass prototype smart glasses back in 2013. Although the company announced intentions to discontinue sales of the product in January 2015, it would be shortsighted to refer to the project as an outright failure. Shortly after Google’s announcement last year, predicted that sales of smart glasses would reach $1 billion in shipments by 2020 and surpass shipments of mobile phones within the next decade ( Meanwhile, Google has remained committed to leading future developments in the space, filing an application with the FCC for a new version of Google Glass in December 2015 (

Alongside Apple and Google, other global tech leaders have thrown their hats into the wearables ring with varying degrees of success. Samsung (OTC: SSNLF), in particular, has illustrated some of the difficulties presented to established firms in targeting the wearables crowd. Despite being one of the first major tech companies to enter the wearables market, Samsung held just over eight percent of the market in 2015, according to IDC ( The research firm expects this figure to fall to just 2.8 percent by 2019.

For investors looking to capitalize on the growth of the wearables market without being exposed to the greater tech industry, pure plays also exist. Fitbit (NYSE: FIT) is one example of a pure wearables play with a sizable share of the burgeoning market. Fitbit’s revenues have been on the rise in recent quarters, and sales more than doubled during 2015. According to an article on The Motley Fool (, the wearables specialist is currently on track to grow an additional 35 percent this year. Still, investing in the future of Fitbit isn’t exactly cheap. The company’s PPS is currently hovering at around $14.80.

GTX Corp. (OTC: GTXO) is a more approachable option for investors seeking to diversify their portfolios in order to cash in on the forecast wearables boom. A self-described ‘pioneer in IoT wearable technology’, GTXO offers comprehensive end-to-end solutions that include location-based hardware, middleware, apps and related professional services. The company’s flagship product is the award-winning GPS SmartSole, which aims to improve the lives of the roughly six million Americans currently living with Alzheimer’s and Dementia, as well as their caregivers. By embedding a GPS tracking device into a comfortable insole, GTXO’s GPS SmartSole provides peace of mind to family members without the need for separate tracking devices and the obtrusiveness and stigma that are often associated with them.

Earlier this month, GTX Corp. released its financial results for the fiscal quarter ended June 30, 2016, which included promising growth. The company’s quarterly revenue was up 36 percent over the previous year, while subscriber revenue increased 133 percent year-over-year. In total, GTXO boasts active subscribers in more than 35 countries around the globe. The company intends to build on these results by adding new customers and subscribers, as well as through a new initiative designed to monetize its numerous intellectual property assets. In line with these initiatives, GTXO recently entered into two new master distribution agreements that will allow the company to scale distribution in certain vertical markets without significantly increasing operational expenses. Key to these efforts will be GTX Corp.’s ability to secure the capital required to keep up with market growth, as alluded to by CEO Patrick Bertagna in a recent news release.

“Lack of sufficient capital for inventory, human resources and infrastructure has been a challenge since our launch last year. It has limited our ability to order appropriate inventory thereby limiting our ability to grow as quickly as we would like,” he stated. “We believe that our increased margins and revenues, along with the new monetization IP campaign, will begin to ease our capital shortage problem. Having said that, we remain focused on building brand and product awareness on a global scale, growing our channels of distribution and increasing sales, subscription revenues and margins in all our product categories.”

For more information, visit

EquityFeed – The Ultimate Trading Platform for Active Traders

August 25, 2016

Every day we have to rely on a market data provider to ensure we have the latest, most accurate information. Because so many depend on our content to make better informed trading decisions, it’s imperative we have access to the most powerful trading tools available. Over the past few years we’ve tested many different trading platforms, but none have come close to EquityFeed.

Here’s just a brief snapshot of all the tools offered with a subscription:

• Robust Filters – The streaming algorithmic filter module lets traders setup technical scans for a continuous flow of trade opportunities.
• Technical Trading Alerts – Quickly see which stocks are making new highs, new lows, breaking price averages, breaking volume averages, moving block trades and much more.
• Daytrade Montage – With this module traders can thoroughly analyze a stock in just a few moments, having access to streaming charts with chosen indicators, dynamic Level 1 and Time/Sales, News and SEC Filings, Level 2 market depth, as well as volume and price averages.
• Market View – A one-of-a-kind tool that sorts and ranks stocks of the exchange(s) of your choice by a wide range of parameters including Price, Volume, # of Trades, Net or % Change and much, much more.
• News and SEC Filings – Monitor news and SEC filings in real-time, instantaneously determining if the market is reacting! It doesn’t get any better than this for those who like to trade off of news, enabling traders to sort or filter news by price, volume or a slew of other criteria.
• Level 2 Depth – See a stock’s order book with all the market makers lined up behind the bid and ask. Known as the best on the street, EquityFeed’s Level 2 module also logs the time and actions of market makers as they happen.
• Limit Alerts – Never miss a critical moment again. Using this module, you can setup alerts for when one of the stocks your watching crosses a specified threshold (such as price, volume, # of trades, etc.). The alerts can be displayed as a flashing popup or sent to you via email.

EquityFeed’s trading platform integrates all these ultra powerful data tools in an easy-to-use interface. To try the platform out for yourself and see what else it is capable of, visit and sign up for a 30 Day Trial.

Let us hear your thoughts below:

2050 Motors, Inc. (ETFM) Moves Forward with Carbon Fiber Auto Assembly Plant as Global EV Market Soars in Q1 2016

August 24, 2016

Even with fuel prices dropping significantly over the last couple of years, which has prompted some industry commentators to predict a slowdown on the electric vehicle market, overall sales reported in the first quarter of 2016 were 42% higher year-on-year ( The Q1 increase is indeed not as high as the figures reported in Q4 2015, which was particularly strong for electric vehicle sales in anticipation of reduced incentives on several markets this year. Nonetheless, plug-in sales in the first quarter totaled an impressive 180,500 units worldwide, with China alone responsible for a considerable portion of the growth, as year-on-year sales in the Asian nation doubled compared to last year.

China remains a significant market for electric vehicles, not only in terms of sales, but also in terms of manufacturing. One of the most revolutionary electric cars on the market at the moment, the e-Go EV sold by 2050 Motors, Inc. (OTCQB: ETFM), is in fact the product of a Chinese company, being engineered and designed by Jiangsu Aoxin New Energy Automobile Co., Ltd. What sets the e-Go EV apart from other electric vehicles is that it is the only such car with a carbon fiber body and parts installed on an aluminum racing car frame and suspension. The entire manufacturing process is done with the help of robotic machines, which lowers both the time and cost of fabrication. The result is an electric car that weighs thousands of pounds less than other similar vehicles on the market, at only 1,450 lbs., and with a carbon fiber body that is five times stronger than steel.

2050 Motors, which has exclusive rights to assemble and distribute the e-Go, says this is the most efficient and affordable electric vehicle ever built, with over three times the battery life of other cars in its class. The vehicle’s battery warranty is eight years with unlimited mileage, the same as Tesla’s (NASDAQ: TSLA) Model S. The company also plans to launch a carbon fiber luxury sedan, the Ibis EV, in the near future.

This might be very soon, as the company recently secured an equity purchase agreement of $10 million for the construction of an assembly plant in Las Vegas. The deal was sealed with Southridge Partners II, LP, a Connecticut-based holding firm specializing in advisory services and direct investment. The facility will be built specifically for the assembly of carbon fiber electric vehicles, including the body and parts being manufactured and shipped from the Jiangsu factory. 2050 Motors is close to completing negotiations with the City of Las Vegas regarding the project, which is expected to bring a great number of high paying jobs to the city.

Additionally, the company is in talks with the Las Vegas Global Economic Alliance for the creation of a foreign trade zone for the assembly factory, which would allow it to bring the car bodies and parts from China without formal customs processing or customs duties until the assembled products leave the trade zone.

For more information, visit

IEG Holdings Corp. (IEGH) Achieving Record Loan Volume through ‘Mr. Amazing Loans’ Brand

August 23, 2016

IEG Holdings Corp. (OTCQX: IEGH) is a provider of unsecured consumer loans in 17 U.S. states through its state licensed operating subsidiary, Investment Evolution Corporation, under the consumer brand ‘Mr. Amazing Loans’. In recent months, IEGH has successfully leveraged the increasing marketability of its consumer brand to promote tremendous growth, achieving a record high in monthly loan volume of $1.13 million in May before announcing a record high in daily loan volume of $150,000 in early June. In July, the company built on this progress, surpassing $13 million in cumulative loan volume. This milestone marked an increase of 140 percent from January 2015, which IEGH’s management attributed to growing recognition of the ‘Mr. Amazing Loans’ brand, low cost lead sources and continued state license expansion.

After announcing second quarter fiscal results that included a 19 percent year-over-year increase in revenue to a record high of $535,356, IEGH gave prospective shareholders some additional insight into the company’s growth strategy for the coming months. IEGH’s management team aims to expand the ‘Mr. Amazing Loans’ brand into 25 U.S. states during 2016, bringing total nationwide coverage to approximately 240 million people, or about 75 percent of the population. To strengthen its cash position ahead of this growth initiative, the company is currently in the midst of a $95.32 million rights offering to its shareholders of record, with plans to use the proceeds stemming from the offering to fund new loan originations and general corporate expenditures. The subscription period related to this offering is underway and set to end on August 29.

Looking ahead, IEGH’s management team expects loan volumes to continue to rise as a result of tightening regulations on the P2P lending sector. Paul Mathieson, chief executive officer of IEGH, reaffirmed this outlook in a recent news release.

“Management believes the substantially increased regulatory and financing scrutiny on the P2P lending sector is a significant positive going forward for the Mr. Amazing Loans business,” he stated. “IEGH is not a P2P lender, however, we expect some of the P2P players will implode, leading to less overall consumer loan provider competition. We anticipate that this will result in cheaper customer acquisition costs for online, state regulated, balance sheet lenders with strong underwriting standards such as IEGH.”

In June 2016, the New York Department of Financial Services issued warning letters to 28 P2P lending agencies as part of an ongoing investigation into the potential adoption of additional regulation measures. The correspondence demanded ‘immediate compliance’ with the state’s licensing requirements for debt collection, transmitting money and mortgage lending activity. This investigation follows a 2008 decision by the Securities and Exchange Commission that required P2P lenders to register their offerings as securities, pursuant to the Securities Act of 1933. The result was the introduction of an arduous registration process to the P2P sector that led a number of lenders to exit the U.S. market. Notably, New York is one of the eight states being targeted by IEGH for expansion in 2016.

For more information, visit

DigiPath, Inc. (DIGP) Cannabis Testing Service Consolidates Position in Nevada

August 22, 2016

The U.S. cannabis industry is booming, with Nevada being one of the country’s most important markets as a proposal to legalize the use of recreational marijuana in the state is expected to pass by a landslide in November. Nevada has already approved the use of medical cannabis in 2000, and the November 8 vote is seen as an opportunity for the state to possibly replace Colorado as the country’s main marijuana tourism destination and maybe even join global destinations for cannabis such as Amsterdam.

A significant part of the industry and arguably the most attractive is cannabis testing services, estimated to generate up to one billion dollars of the overall $35 billion the industry is expected to generate by 2020. Testing services are crucial for the industry’s development, especially on newer, self-regulated markets such as Nevada. Capitalizing on these trends, DigiPath, Inc. (OTCQB: DIGP), via its cannabis testing service DigiPath Labs™, has its foot set firmly in the Nevadan market, after opening a state-of-the-art testing facility in Las Vegas and already securing contracts with a great number of the state’s licensed cultivators.

In August alone, the company announced new service agreements with three leading cultivators located in the Las Vegas area: The Clinic Nevada LLC, Green Extracts – a Moxie Seeds & Extracts licensee, and Vegas Valley Growers. Based in Las Vegas, The Clinic has numerous cultivation and retail locations in Colorado and Illinois and, according to COO Jon Marshall, it chose DigiPath Labs as its cannabis testing provider because the service has ‘gone above and beyond’ in delivering reliable results with a quick turnaround. Moxie Seeds & Extracts is one of the foremost producers of cannabis extracts, manufacturing a wide range of extracts including hashes, oils, tinctures, and seeds for various cannabis strains. Moxie picked DigiPath Labs as a testing service for its licensee Green Therapeutics after being impressed by the quick 48-hour turnaround, its impressive staff of scientists and superior customer service. Similar words of appreciation for DigiPath Labs’ turnaround time, customer service and science staff came from Vegas Valley Growers COO Marla Wilson. Vegas Valley Growers is the exclusive licensee in Nevada of Bhang Corporation, a leading U.S. manufacturer of cannabis infused products, such as chocolate, as well as various types of cannabis vaporizers and refills.

The new deals will help DigiPath consolidate its position on the Nevadan market, where it aims to become the leading provider of cannabis analytic testing and set the industry standard for cannabis and cannabis-based product testing, using both proprietary operating procedures and FDA-compliant lab equipment. The company offers the fastest testing turnaround on the market – 48 hours to analyze test samples and return the results, with the help of ultra-sensitive analytical equipment produced by top diagnostics instrumentation manufacturer Agilent Technologies (NYSE: A). Under the management of Dr. Cindy Orser, a reputable biotech and diagnostic industry pioneer, the Las Vegas testing facility’s main goals are to enable manufacturers to offer safe products, free of contaminants, and to provide detailed cannabinoid profiles for cannabis-based medicine so as to allow patients to benefit from the right product for their needs.

For more information, visit

Medical Transcription Billing, Corp. (MTBC) (MTBCP) Full-Spectrum Web EHR & Services Platform Poised to Pop as Healthcare IT Market Booms

A recent report ( on the global Healthcare IT (HIT) market from Technavio projects an attractive seven percent CAGR for the space over the next four years, when the U.S. sector alone will generate upwards of $75 billion annually. The analysts at MarketsandMarkets affirmed this outlook in their report on the sector late last year (, projecting that the global healthcare IT market will see a CAGR nearly twice the Technavio figure when all sources are accounted for, coming to represent a total market valued at somewhere in the neighborhood of $228 billion by 2020.

The biggest names in the industry today are looking to capitalize on this growth, with players such as Athenahealth (NASDAQ: ATHN), Allscripts (NASDAQ: MDRX), GE Healthcare (NYSE: GE), Mckesson (NYSE: MCK), Oracle (NYSE: ORCL), Philips Healthcare (NYSE: PHG), and Siemens Healthcare (OTC: SIEGY) all making sizable bets on the future of the space. Another important aspect of this growth story is the proliferation of mobile devices, as the EHR (electronic health records) landscape becomes increasingly saturated with mHealth features like mobile apps and digital personal health records. Consider the installed base of some 2.6 billion smartphone users worldwide (, a figure set to grow 134 percent by 2020, and you can start to understand why the mobile medical workplace is perhaps a foregone conclusion. North America, as the currently (and for the foreseeable future) largest regional segment of the HIT space, is no doubt where the majority of the global market’s action will be. So it makes sense to start looking at competent, multiple-threat operators in the healthcare IT market that are accessible to the average retail investor, and which have an established footprint in the states.

Trading under a dollar, with a rapidly growing portfolio of products and service offerings, Medical Transcription Billing (NASDAQ: MTBC) (NASDAQ: MTBCP) for instance has made some impressive headway in this sector since its IPO in 2014. The company has rapidly blossomed into one of the most compelling full-spectrum, cloud-based EHR (ChartsPro™), practice management (PracticePro™) and mHealth solutions providers around. MTBC packs a powerful one-two punch of products and services that collectively constitute a unified, database-driven and fully integrated WebEHR platform, spanning everything from billing, data management, transcription, chat scribing, and business intelligence, to value-added and consultancy services. This is exactly the kind of one-stop-shop healthcare customers in this market are looking for.

Founder, chairman and CEO Mahmud Haq, as well as president and Director Stephen Snyder and CFO Bill Korn, made quite a showing at the 2016 Marcum MicroCap Conference ( back in June, just before the launch of the company’s hospital receivables management service via acquisition of New Jersey healthcare financial specialists WFS Services. The WFS Services acquisition superbly augmented the company’s already strong position in ambulatory (outpatient) services and enables MTBC to aggress the huge opportunity of underserved demand in patient balance collection and aged insurance accounts receivable. By exploiting its unique technological advantages and vast sums of expertise in order to serve the ominously compounding need for solutions to the nuanced and often arduously difficult challenges of collection and aged insurance accounts receivable, MTBC is setting itself up for long-term growth.

The company has had a laser-focus on strategic growth toward its 2016 objectives, scoring a spate of notably appropriate recent acquisitions, including Renaissance Physician Services (Tennessee), Gulf Coast Billing (Texas), and the WFS Services deal. And yet MTBC managed to wrap up Q2 with $6.6 million in cash on the balance sheet. This an extraordinarily visionary approach to this space for a relatively young company like Medical Transcription Billing, but management can read the handwriting on the wall: the healthcare IT market is only going to get hotter. Strengthening its already enviable position in the sector through shrewd acquisition is how the company set a new milestone for revenue growth from Q1 to Q2 this year, and the company hopes to continue this trajectory on the strength of things such as having already developed a comprehensive ICD-9 to ICD-10 mapping and transitioning solution.

And it is not just the increasing complexity of the space that will allow full-spectrum operators like MTBC to prosper amid all this demand growth. As new systems must be rapidly defined and rolled out to handle an ever more stringent regulatory environment, mounting demand for knowledgeable consultancy and expert services will likely continue to increase at a geometric rate. Medical Transcription Billing will prosper because its suite of offerings is able to deliver considerably enhanced efficiency and profitability metrics, something which is of paramount concern to everyone in the industry, as there exists a pressing requirement to bring down overall healthcare costs.

A set of common drivers behind all this demand growth are made strikingly clear in both of the aforementioned reports. Chief among these drivers is the rise-and-rise of EHR (electronic health records) solutions in general, spurred on by a concomitance of actors, such as the prevailing lack of in-house IT capabilities among most sector operators, the ease/robustness of cloud services, and the inherently complex regulatory environment that just gets more nebulous with each passing year. The MarketsandMarkets and Technavio reports mentioned earlier were both keen to acknowledge how everything in the industry is shifting toward external cloud and SaaS (software as a service) solutions. One of the fastest growing segments of the HIT market is healthcare provider solutions, where a projected 16.4 percent CAGR (MarketsandMarkets) shows just how hot the game truly is when it comes to solving the regulatory compliance/assurance woes that face today’s healthcare providers.

This is an area where something like MTBC’s fully integrated Meaningful Use Stage 2-certified and web-based EHR platform ChartsPro really shines. ChartsPro gives a practice everything required to easily execute a Meaningful Use Stage 2 implementation, including the necessary training, and the company even provides an MU expert to each of its clients as part of its regulatory compliance services package. Ranked among the best of the best by Utah-based health informatics research outfit and industry benchmark KLAS, and certified by the ONC (Office of the National Coordinator for Health Information Technology), ChartsPro can handle all the critical functions of a medical practice and is just the kind of highly intuitive, yet powerful framework that the clinical solutions segment of the healthcare IT market now demands. Notably, this segment has a projected 19.8 percent CAGR through 2020.

Whether it’s chart creation backed up by the company’s digital transcription technology, ChartScribe (a digital audio dictation to complete charts solution which is fully integrated into the ChartsPro architecture), or a host of other mission critical tasks, the web native ChartsPro platform is ideal for an increasingly work-anywhere digital environment full of tablets, smartphones, and other mobile devices. Correct and timely patient charts are essential at every practice and ChartsPro handles this key task beautifully, while delivering similarly excellent results when it comes to things like document management, claim creation, e-prescription, lab test ordering, PHR handling and scheduling.

The consistently emerging PM (precision medicine) model of healthcare, which is reinforced by a similarly emergent technical foundation and the need for tailored medicine in areas like cancer, will continue to be a substantial driver both for the HIT space, and for MTBC itself. This single market alone will likely grow to nearly $88 billion by 2023 according to a report by Global Market Insights (, with factors such as genome sequencing ($8 billion last year), and new drug discovery playing major roles. The White House has dedicated $55 million toward a new PM initiative, the industry has responded, and now it will be up to operators in the healthcare IT sector to pick up the ball and run with it. The explosion of diagnostics alone could send a multiple-threat WebEHR outfit like MTBC into the stratosphere. It should be interesting to see how things shake out for this aggressive young cloud-savvy player.

For more information, visit

Lucas Energy, Inc. (LEI) is Positioning Itself to Capitalize on Current Market Environment

In recent months, the economy has seen a downturn in energy prices. With some energy companies filing bankruptcy, Lucas Energy, Inc. (NYSE MKT: LEI) has not only survived the recent downturn but positioned itself perfectly to benefit from the current market environment. Furthermore, the company plans to expand on its current national footprint.

Lucas Energy, Inc. is a growth-oriented, independent oil and gas company based in Houston. LEI has working interests in over 10,000 net acres in South Texas with reserves valued at approximately $112 million, as well as other reserves estimated to be worth $60 million. All of the company’s acreage is located in the Eagle Ford shale and the Austin Chalk producing formations.

In 2012, LEI appointed a new management team with a vast amount of experience that positioned the company for growth and opportunity. Since the appointment of this new expert team, the company has reduced overhead, improved balance sheets, made field operations more efficient, and resolved legacy legal issues.

Today, the company’s main goal is to develop its most valuable asset in the Eagle Ford shale. The aim is to increase production and generate positive cash flow. As part of these efforts, the company made public a purchase agreement to acquire a working interest in producing properties in the Mid-Continent region. This acquisition will play a key role in the growth strategy of the company.

With this transaction, the company aims to produce more energy on a daily basis. These changes have led Lucas Energy, Inc. to plan a name change to Camber Energy in the near future, a name that LEI believes is better suited to the vision of the company. Although the oil and gas industry has not been as strong in recent times, LEI has put together a three pronged strategy. This includes developing its current assets, capitalizing on the down cycle, and pursuing further material acquisitions.

For more information, visit

MannKind Corp. (MNKD) Relaunches Groundbreaking Inhalable Insulin Afrezza®, Promotes New Copay System

August 19, 2016

With over 29 million Americans living with diabetes, and more than 86 million with prediabetes, this disease is the seventh leading cause of death and swallows approximately 20% of nationwide healthcare spending, according to Centers for Disease Control and Prevention (CDC) statistics ( Healthcare officials, patients and doctors alike are always actively searching for new therapies or innovative yet affordable treatments to combat this disease.

This is where leading biopharmaceutical company MannKind Corporation (NASDAQ: MNKD) and its groundbreaking inhalable insulin product Afrezza® come in. Touted as the first successful insulin inhaler on the U.S. market, Afrezza is a fast-acting inhalable insulin powder designed to be used in conjunction with regular type 1 and 2 diabetes treatments to help lower post-meal blood sugar spikes.

Beginning in July, MannKind relaunched Afrezza Inhalation Powder on the domestic market under its own branding, and the treatment is now available with major wholesalers, as well as by prescription in any retail pharmacy.

Leveraging its two-year experience in patient selection and copayment, the company has also announced several programs to promote patients’ access to Afrezza therapy. These include:

  • Enhanced copay assistance designed to lower insured patients’ out-of-pocket cost to $15 per month
  • Patient reimbursement support program, MannKind Cares
  • Bureau to educate and inform healthcare providers about the benefits of Afrezza
  • New titration pack that allows patients new to Afrezza more flexibility in adjusting their daily dosage

The new programs will join MannKind’s national salesforce, all of whom have extensive experience with diabetes and Afrezza, in its efforts to help enhance and streamline patients’ and providers’ experience with this key therapy. The company is committed to ensuring the treatment remains available to all diabetes patients in the U.S., without any disruption in supply.

The July relaunch came after the company released six more analyses of the pre-meal treatment, demonstrating a faster onset and shorter duration of action than with mealtime fast-acting insulin treatments. The findings, presented at the 76th scientific session of the American Diabetes Association, show that, compared to Eli Lilly and Company’s (NYSE: LLY) insulin lispro injection, Afrezza has a 50% faster onset and a 2-3-hour shorter duration of action.

The data supports the use of this therapy for rapidly controlling high glucose levels, according to the chief medical officer of MannKind, Raymond W. Urbanski, MD, PhD. Unlike injectable insulin, which risks causing hypoglycemia after a meal if dosed incorrectly, Afrezza works in the body more rapidly and leaves the bloodstream faster, offering an ideal balance between glucose control and a lower risk of hypoglycemia.

To find out more about MannKind Corp. and its innovative Afrezza Inhalation Powder insulin, visit

Smith-Midland Corp. (SMID) Primed to Build on Position at Forefront of the Domestic Precast Concrete Market

August 18, 2016

Despite its more than five and a half decades at the forefront of the domestic precast concrete market, Smith-Midland’s (OTCQX: SMID) recent coverage gives the impression that the company has only recently sprung into existence, fully armored, like Athena being born from the forehead of Zeus. Currently enjoying a nice pop following the release of its Q2 financials on August 11, shares of this ceaselessly innovative precast concrete manufacturer are now trading around pre-2008 highs, with considerable tailwind in the form of numerous recent project successes.

Globally speaking, the precast concrete industry itself is seeing something of a rebound, after a tough recession period and ongoing adjustment to China’s growth slowing down. A recent study by DecisionDatabases ( even projects a CAGR of 3.2 percent moving forward through 2022, when the global precast concrete market is expected to reach upwards of $58.7 billion.

Subsequent to the post-2008 dip ( that was experienced by just about everyone, SMID has been a portrait of the old adage that, “slow and steady wins the race.” The company has quietly been advancing the state-of-the-art in precast concrete design, manufacturing, and delivery systems, while landing contract after contract. This constant innovation is readily exemplified by the company’s high-performance SlenderWall™ system, a lightweight (66 percent lighter than traditional precast) architectural cladding system, which is as robust as it is easy to install. Recently described by Rodney Smith, chairman and CEO of Smith-Midland, as the company’s most profitable product, the SlenderWall is a feature-rich and proven system that not only addresses the typical cost and logistical metrics of competing solutions beautifully, it actually offers superior structural advantages as well. This exterior cladding system is effectively isolated from wind loading, seismic shock, expansion/contraction, movement of the underlying steel frame, and other structural forces experienced by the primary structure.

Fully code compliant and available with a proprietary (optional) Lift-and-Release™ panel-landing system, which allows an already simplified installation to be done even faster, SlenderWall is also the only wall system in the industry today to fuse together the four key technologies required for an efficient solution that can easily be applied to either new construction, or renovations. By skillfully leveraging its architectural precast concrete manufacturing expertise, Smith-Midland has found a way to embed high-tech PVA fibers into its products, making the SlenderWall cheap to install, yet able to provide a long lifespan of maintenance-free use. And these beauties are secured with a combination of thermal coated anchors and heavy gauge galvanized steel (or stainless steel studs), making this lightweight solution far more sturdy and long-lasting than one might ever expect.

SlenderWall is the perfect economical and efficient choice for a variety of 20,000 square foot plus jobs, whether it is a renovation like the 2013 Johns Hopkins Medicine (Baltimore Campus nine-story Nelson Harvey inpatient facility) job (, or a massive new undertaking like the recently announced 2-mile-long Port Imperial redevelopment project in West New York, New Jersey. This sizable (42,000 square feet of SlenderWall) undertaking with New Jersey’s largest homebuilder, K. Hovnanian (NASDAQ: HOVNP), is a striking example of how prominent SMID has become as an east coast precast concrete manufacturer.

Smith-Midland primarily serves the construction, transportation and utilities markets, as well as the agricultural, beach restoration (via Beach Prisms, a shoreline erosion control barrier system) and small precast building markets (via wholly-owned subsidiary Easi-Set Industries), with a wide variety of brilliantly designed solutions that it sells, licenses, and/or rents to various customers. The company actually cut its teeth back in the 1960s as Smith-Cattleguard Company, which was founded by Rodney Smith and his father when the business was just about precast concrete farm products. This rich tradition is still carried on today in the form of an array of highly durable cattle guards and feed bunks, as well as waste storage and watering systems.

The market’s warm reception to SMID’s Q2 financials is not surprising given that the company’s long-term growth story (slightly hampered by an admittedly sluggish Q1) has been supercharged of late by increased opportunities in several of its primary end markets, due in large part to generally improving underlying economic conditions as well as the company’s own continually growing brand presence. Perhaps the most notable market here for the company is transportation, where SMID operates via its Concrete Safety Systems (CSS) subsidiary. CSS was founded in 1977 as the then nascent industry’s first and only entity focused specifically on leasing highway safety barriers to contractors and state highway departments. CSS is a full-service barrier rental company that delivers, installs and then carts away the company’s J-J Hooks positive connection barrier system, which is ideal for roadwork (freestanding, bolted or pinned), and also security functions (especially when configured with an optional fence top).

CSS is housed at the company’s primary 44,000 square foot facility in Virginia. Between this primary facility, the company’s Smith-Carolina 8,000 square foot facility and the soon to be 40,000 square foot Smith-Columbia facility, SMID will have an enviable 300 mile-wide striking distance up and down 800 miles of the East Coast. This is a considerable territory, stretching all the way from New York City, to the southern Georgia border. The new Columbia location shores up coverage of the Atlanta metropolitan area nicely for SMID, as well as nearly a dozen military bases throughout South Carolina and Georgia, putting Smith-Midland’s legendary ability to innovate front and center when it comes to aggressing a whole host of projects in the region.

In many ways, the precast industry is overshadowed by the looming predominance of government initiated infrastructure projects, but SMID has done a marvelous job diversifying into the rapidly growing residential and commercial construction arenas. At the same time, SMID has positioned itself perfectly to benefit from the $305 billion, five-year highway infrastructure bill passed late last year in December (, and the company is likely already experiencing a boost because of the bill’s passing. With presidential candidate Trump talking about building a wall on the border between the U.S. and Mexico (a project that would require setting up localized construction facilities for regional manufacturing the way SMID has done for the East Coast), it is not unthinkable that a company such as Smith-Midland could experience considerable upside on sector momentum alone, even without landing any contracts.

But it’s not like the company even needs such a huge project, as even a cursory glance at this year’s news reveals a spate of sizable contracts. Contracts range from an Easi-Span Building used in Illinois as a township’s water supply aerator, to a set of two massive Virginia DOT road projects, which will utilize a whopping 300,000 square feet of the company’s proprietary SoftSound™ sound absorptive composite panels. In the last decade of official data alone, we have added some 6.5 percent more paved roadway to the U.S. nationwide, bringing the total number of miles of paved roads up to well over 2.744 million. Demand for outdoor noise barriers, primarily associated with stopping traffic noise from reaching residential communities, is slated to rise 3.7 percent per year through 2019 in the U.S. alone, according to a recent study by Freedonia ( That same study sees the overall U.S. market as growing to $191 million over the same interval, as a good chunk of that $305 billion highway infrastructure package looks like it could go directly toward state DOTs putting up more noise barriers alongside highways.

Smith-Midland is the portrait of an under bought niche leader and remains quite accessible to the average retail investor at around three bucks a share, especially when compared to other sector players such as CRH plc (NYSE: CRH), and that is despite SMID trading very near to its 52-week high. With many, many takers for its cutting-edge precast solutions, a perfect storm of potentials exists for the company. Smith-Midland also just so happens to have the unquestionable experience and leadership needed to truly capitalize on this storm of potentials for its shareholders.

For more information, visit

Net Element, Inc. (NETE) Expanding Payments Market Share Internationally as Tech Giants Jockey for Position in the U.S.

August 15, 2016

Google Wallet, the peer-to-peer payments service developed by Google (NASDAQ: GOOG; GOOGL), was first released in the United States in September 2011. From the beginning, Google Pay allowed its users to make point-of-sale purchases with their mobile devices using near-field communication (NFC) technology. Four years later, the multinational tech giant shifted its NFC payments to Android Pay, limiting contactless payments to users of its Android mobile operating system. This move made sense, as Apple (NASDAQ: AAPL), Google’s primary competitor in the mobile operating system space, released its proprietary Apple Pay platform months earlier in October 2014. Both Apple and Google boast expansive availability in the U.S. According to a 2015 report by The Verge (, Android Pay is available on more than 70 percent of available Android devices and accepted across a network of more than 700,000 merchants.

With these statistics in mind, the rising tide surrounding contactless mobile payments remains under the radar. In December 2014, reported ( that U.S. proximity payment transaction values doubled from 2012 to 2013, and eMarketer projections call for continued growth in the years to come as consumers warm to the idea of paying with their phones. Research firm Forrester shares this vision. In a 2014 report, Forrester predicted that mobile-based payments in the U.S. will reach $142 billion in volume by 2019, up from just $50 billion at the time of the study.

The maturation of the mobile wallet market will create opportunities for tech giants like Google and Apple, to be sure; and other household names, such as PayPal (NASDAQ: PYPL), Visa (NYSE: V), Chase (NYSE: JPM) and AT&T (NYSE: T), have already thrown their hats into the ring as well. Just two years ago, the market leader in mobile payment apps, according to the report, was Starbucks (NASDAQ: SBUX), with an impressive 29 percent of all U.S. smartphone owners who had used mobile payment apps to make a purchase having done so with the coffee chain’s proprietary wallet app. While this peculiar statistic demonstrates the relatively low barriers of entry that currently exist in the mobile wallet space, it also highlights the difficulty companies are having in getting consumers to take advantage of the convenience of contactless payments. A 2015 study by Accenture ( found that while 52 percent of North Americans are “extremely aware” of the availability of mobile payments, only 18 percent use them on a regular basis.

In an April 2015 poll by Statista (, PayPal landed in the top three mobile wallet services in the U.S. in terms of user satisfaction, and this favorability has resulted in steady expansion of payment volumes. In the second quarter of 2016, PayPal’s net payment volume totaled $86.2 billion, up 28 percent year-over-year. This growth is telling of the value proposition offered by PayPal to its consumers, which extends across both Android and iOS, as well as integrating within merchant-oriented payment platforms to combine convenient payment options with targeted coupons for frequent shoppers and other services. Throw in Venmo, the mobile payment service acquired by PayPal in 2013 for $800 million, and its active user base of more than 1.5 million, and you’ve got the makings of a serious competitor for both Apple Pay and Android Pay.

Of course, the U.S. is just the tip of the iceberg when it comes to the expected proliferation of digital wallets in the coming years. In September 2015, a MasterCard (NYSE: MA) study found that digital wallets were the primary topic of discussion regarding payment innovation in a number of the world’s largest emerging markets, including India, China, Indonesia, Malaysia, Nigeria and the UAE ( The study went on to find that these markets are particularly ripe for innovation, with people pointing toward security as their primary concern in adopting electronic payment methods. As a result, MasterCard is looking into the integration of facial recognition software and biometrics in order to make payments both easier and more secure.

PayStar is a less-known play in the digital wallet space that’s targeting the needs of emerging markets. Founded in 2006, the company provides financial institutions with a complete solution enabling remittance services, merchant services, mobile payments and payroll services for their customers. In addition to its operations across North America, PayStar offers flexible services that meet the unique needs of markets in the Middle East, Europe, Asia and Africa. The company is currently in the process of expanding its mobile payroll and remittance services throughout the Middle East, beginning with Qatar, the UAE, Oman and Saudi Arabia. Through partnerships with local financial institutions, PayStar is positioned to market its services to more than 15 million migrant workers in Qatar and Oman alone.

For the investment community, PayStar’s established and growing position on the global mobile payments stage is particularly intriguing following the recent announcement that Net Element, Inc. (NASDAQ: NETE), a provider of global payment technology solutions and value-added transactional services, has entered into a binding letter of intent to acquire a majority interest in the company. Subject to closing, Net Element intends to create one or more entities that will house the combined assets of PayStar and Nexcharge, a proprietary payment processing, fraud management and merchant management platform. Net Element will own a 51 percent interest in these newly-formed entities and maintain an exclusive option to acquire the remaining 49 percent interest for 12 months following the closing of the transaction.

With the planned acquisition of interests in PayStar and Nexcharge, Net Element will look to bolster what is already a sizable presence in the global payments industry. Just last month, the company’s wholly-owned subsidiary, PayOnline, was ranked as a leading payment gateway by independent market analytics agency Building on this position, PayOnline recently introduced a new adaptable, multi-channel payment interface to more than 10 million online shoppers in over 3,000 international e-commerce markets. Combining this commitment to innovation from within with an aggressive M&A strategy has Net Element prepared to expand its presence in emerging markets, as discussed by CEO Oleg Firer in a recent news release.

“These acquisitions will allow Net Element to present transactions for processing directly to Visa, MasterCard, American Express and other networks, as well as expand our presence in GCC region and other selected markets,” he stated. “These acquisitions will add to the growth of our business and increase market share internationally.”

With the persistent focus on the domestic mobile payment scene, it’s easy to overlook the immense opportunities currently being presented by emerging markets. Adults in markets across Africa, Asia and Latin America still lack access to formal financial institutions, as noted by EY ( As a result, mobile commerce options such as digital wallets already outpace traditional bank accounts in several emerging countries. While newcomers in the domestic market are forced to go head-to-head with the likes of Google and Apple, Net Element, through the acquisition of interests in PayStar and Nexcharge, is set to quietly expand its already sizable presence on the global stage by continuing to meet the unique needs of consumers in emerging markets.

For more information, visit

US Nuclear Corp. (UCLE) Leveraging Extensive History in Nuclear Power and Research Sectors to Promote Sustainable Financial Growth

August 9, 2016

US Nuclear Corp. (OTC: UCLE) specializes in the design, development and manufacture of radiation detection instrumentation. Through subsidiaries Overhoff Technology Corp. and Optron Scientific Company, Inc., UCLE harbors over a century of experience addressing the unique instrumentation needs of the nuclear energy industry, as well as industries associated with emerging technological processes, such as thorium and molten salt reactor technologies, both domestically and internationally. The company’s customers include a variety of United States government agencies, the U.S. military, Homeland Security, scientific laboratories, universities, hospitals and nuclear reactor facilities located around the world.

UCLE’s roots in the nuclear power industry are extensive. Optron Scientific Company, doing business as Technical Associates (TA), was founded in 1946 as a spinoff from the Manhattan Project, the research and development program that led to the production of the first nuclear weapons during World War II. The company’s founders are credited with the design and construction of the first industrial grade radiation monitors, which were used to safeguard the scientists charged with building the world’s first atomic bomb. In the more than six decades that followed, TA established a position at the head of the industry for its custom-tailored radiation measurement and safety instruments.

Similarly, Overhoff Technology has maintained a reputation as the world’s leading manufacturer of tritium monitors for nearly 40 years. Since its founding, Overhoff has been awarded contracts by the United States Department of Defense and has sold tritium equipment to nuclear power facilities in China, South Korea, Canada, Argentina and the United Kingdom, among others.

With the combined expertise of these two operating divisions leading the way, UCLE has continued to post strong international growth in recent quarters. For the fiscal year ended December 31, 2015, the company reported sales revenues in excess of $2.6 million, marking an increase of 62 percent from the previous year. Likewise, UCLE successfully rebounded from a net loss of $321,505 in 2014 to record net income of $399,416 for 2015. Capping off the solid results, the company’s gross margin rose by eight percent in 2015, and its general and administrative expenses fell by 5.3 percent. Robert Goldstein, the company’s president, CEO and chairman, spoke about these results in a May news release.

“We started off strong in 2015 and kept up the momentum throughout the entire year, as demonstrated by our vigorous increase in sales revenue and earnings per share,” he stated. “The recognition and quality of our tritium monitors has allowed us to capture new opportunities in the rising nuclear power and research sectors, while continuing to service our world-wide base of existing customers.”

Looking to build on its 2015 momentum, UCLE has continued to expand its foothold in the international nuclear power industry in recent months. After reporting profitable annual results, the company announced the reception of a new order totaling $235,000 from its representative in Canada, Radiation Measurement Systems. This order is particularly noteworthy, because the Canadian government has allocated several billion dollars toward refurbishing a number of existing reactors dispersed throughout the country. As one of the original suppliers for many of these reactors, UCLE is strategically positioned to capitalize on this investment as work proceeds.

UCLE has also continued to innovate and push the industry forward, as Goldstein alluded to in an interview with SNNLive ( The company recently implemented drones in order to improve the flexibility of its radiation detection instrumentation. Among the advantages offered by this technology, Goldstein points toward location and rapid deployment as game changers. By offering the capability to measure radiation levels directly above an impacted area, such as a burning hospital or overturned railcar, mere moments after a potentially dangerous chemical or radiation related accident has occurred, users can access critical data that would be otherwise unavailable, effectively protecting the wellbeing of both first responders and the general public.

For more information, visit

Let QualityStocks Help You Navigate the Small Cap Market Terrain

August 4, 2016

Simply put, the small cap market is huge. Nearly 8 out of 10 companies that publicly trade in the United States have a market capitalization of less than $500 million. A surprising 40% of the businesses that trade on Nasdaq have a market capitalization of less than $250 million.

Yet these companies get very little if any analyst research coverage on Wall Street. You may have 52 analysts covering a $468 billion company like Apple, but practically no one covering the small cap company. The investment news media consisting of broadcasts media like CNBC or the magazines and financial newspapers also rarely mention small caps. As a result, the small cap’s stock price rarely reflects the company’s future prospects.

Yet small companies are the true leaders of innovation and creativity. Large companies are bureaucratic monstrosities. Think of the film Office Space where computer engineers stuck in cubicles feel their creativity is stifled while they are focused on pleasing middle management writing Testing Procedure Specification (TPS) reports. Large corporations have become totalitarian work environments where the CEOs are acting as dictators looking over Stalinesque bureaucracies and even their brightest staff members feel as if they are merely renting themselves to the company for a living. The large organizational hierarchies of big cap companies are slow in making decisions and require sticking to established stagnant procedures. Startups require innovative entrepreneurs, and that typically isn’t in a job description for a large company. An innovative entrepreneur would most likely be deemed a threat by corporate middle management.

Small cap companies are hampered by little if any bureaucracy and this leads to rapid decision making, fast adaptability to quick changing markets, and a willingness to take on the risk of new ideas. Large companies sometimes throw large amounts of money to innovate and get nowhere due to ineffective internal communication within their own departments. Clear communication among internal staff and a lack of funds triggers small companies to come up with different, unique, solutions to solve the problems that lead to innovations.

Small cap entrepreneurs are the visionary business people that do market research, create business plans, seek out investors and financing, and then strive to create products and services that utilize a country’s resources. They are the true job creators, and not the management of large corporations that seek to enhance profits by off-shoring labor or replacing people with automation. They are the value waiting to be unlocked in the small cap market.

Let QualityStocks become your portal to small cap investment success

QualityStocks can be your first step to researching small companies on the leading edge of entrepreneurial innovation.

For over 8 years, QualityStocks free daily newsletter has been providing quality investment ideas to small cap investors. QualityStocks delivers the only newsletter tracking the stock tips of hundreds of other investment newsletters, and providing a ‘One-Stop Look’ at the daily highlights of the small cap market. Once you begin subscribing to the QualityStocks daily newsletter, you will wonder how you ever managed without it.

For a free subscription, visit

Let us hear your thoughts below:

IntelGenx Technologies Corp. (IGXT) Represents a New Generation of Oral Drug Delivery Technologies

August 1, 2016

Montreal-based IntelGenx (OTCQX: IGXT), a leading oral drug delivery technology company, uses a suite of proprietary technologies to provide its pharmaceutical partners with a range of superior and cutting-edge drug delivery solutions. The company’s underlying mission is to be the primary medical choice when it comes to oral solid dose innovation.

IntelGenx proprietary technologies include both film and tablet platforms:

VersaFilm™ enables the development of oral thin films for enhanced oral drug delivery, offering:

  • Rapid disintegration without the need for water
  • Quicker buccal or sublingual absorption
  • Potential for faster onset of action and increased bioavailability
  • Potential for reduced adverse effects by bypassing first-pass metabolism
  • Easy administration for patients who have problems in swallowing: pediatric, geriatric, fear choking and/or suffering from nausea (e.g., nausea resulting from chemotherapy, radiotherapy or any surgical treatment)
  • Pleasant taste
  • Small and thin size, making it convenient for consumers
  • Can be used for veterinary applications

VersaTab™ multilayer tablet technology offers a new level of controlled-release tablets:

  • Linearization of the release profile using controlled erosion of inactive cover layers
  • Reduction in peak plasma concentration reduces side effects
  • Potential to deliver multiple actives with independent release profiles
  • Separation of active ingredients to avoid chemical incompatibility
  • Improved patient compliance due to reduced dosing frequency

AdVersa™ is a mucoadhesive tablet for controlled rate release of active ingredients:

  • Fast mucosal absorption formulations for highly permeable drugs
  • Improved bioavailability
  • Avoid high drug metabolization
  • Limited gastro-intestinal exposure
  • Equal therapeutic effect achieved while reducing API loading
  • Increased absorption of poorly soluble API
  • Rapid or immediate release delivery
  • Versatile residence time achieved to enhance/control absorption
  • Targeted profile concentrations maintained
  • Improved patient compliance

With these technologies, IntelGenx has developed a growing portfolio of products, including:

  • Rizaport, the first rizatriptan oral disintegrating film for the treatment of migraine to achieve EU marketing approval
  • Tadalafil, one of the three major PDE5 inhibitors in the erectile dysfunction market, a film-based product offering longer duration of action and less food effect, and improved discrete dosage form that does not require water intake
  • Loxapine, an oral film for the treatment of anxiety and aggression in patients suffering from schizophrenia or bipolar 1 disorder
  • Montelukast, for the treatment of degenerative diseases of the brain, such as mild cognitive impairment and Alzheimer’s disease, the most prominent form of dementia
  • Forfivo XL® (Bupropion extended-release), the first 450 mg bupropion HCl tablet indicated for Major Depressive Disorder to be approved by the FDA
  • INT0028, an improved product formulated using AdVersa™ containing dronabinol (THC) for the symptomatic management of neuropathic pain

In addition, IntelGenx has become a source of comprehensive pharmaceutical services to its partners, providing R&D, clinical monitoring, IP protection, analytical method development and regulatory services.

For more information on the company, visit


Select A Month
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008
  • February 2008
  • January 2008
  • December 2007
  • November 2007
  • October 2007
  • September 2007
  • August 2007
  • July 2007
  • June 2007
  • May 2007
  • April 2007
  • March 2007
  • February 2007
  • January 2007
  • December 2006
  • November 2006
  • October 2006
  • September 2006
  • August 2006
  • July 2006
  • June 2006
  • May 2006
  • April 2006
  • March 2006
  • January 2006
  • December 2005
  • October 2005
  • September 2005
  • Search


    Select A Category
  • 21st Century Holding Company TCHC (1)
  • 5BARz International Inc. BARZ (12)
  • 5G Wireless Communications Inc. FGWC (8)
  • A.P. Pharma Inc. APPA (3)
  • Abazias Inc. ABZA (2)
  • ABV Gold ABVG (11)
  • ACME Sports & Entertainment Inc. ASEN (2)
  • Adaptive Medias Inc. ADTM (6)
  • Advanced ID Corp. AIDO (5)
  • Advanced Medical Isotope Corp. ADMD (10)
  • Advanced Resources Group Ltd. AVRG (3)
  • Advanced Viral Research Corp. ADVR (9)
  • Advanced Visual Systems Inc. AVSC (10)
  • Advanced Voice Recognition Systems Inc. AVOI (11)
  • Advanced Wound Technologies Inc. AWTM (4)
  • Advaxis Inc. ADXS (2)
  • Agora Holdings Inc. AGHI (28)
  • Ahead of the Bulls (1)
  • AISystems, Inc. ASYI (11)
  • Aladdin Trading & Company ADTD (29)
  • All American Gold Corp AAGC (13)
  • All Asia Licensing Inc. AASI (1)
  • ALL Fuels & Energy Company AFSE (49)
  • All Grade Mining Inc. HYII (3)
  • All Penny Stocks (3)
  • Allarae Healthcare Inc. ALHI (5)
  • Alliance Creative Group ACGX) (15)
  • Alliance Recovery Corp. ARVY (34)
  • APTD (2)
  • Alpine TLI Group Inc. APGR (7)
  • ALR Technologies Inc. ALRT (9)
  • Alternative Construction Technologies Inc. ACCY (10)
  • Alternative Energy Development Corp. ADEC (1)
  • Alternative Fuel Technology Inc. AFTC (1)
  • Alternet Systems Inc. ALYI (47)
  • AM Oil Resources & Technology Inc. AMOR (8)
  • Amarin Corp. AMRN (2)
  • Amaru Inc. AMRU (2)
  • Amerex Group, Inc AEXG (16)
  • American Capital Partners Inc. APRJ (1)
  • American Fiber Green Products Inc. AFBG (1)
  • American Oriental Bioengineering Inc. AOB (3)
  • American Racing Capital Inc. AMRA (2)
  • American Software (2)
  • Amgen Inc. AMGN (2)
  • AmMex Gold Mining Corp. AMXG (2)
  • Ampex Corp AMPX (1)
  • Andover Medical Inc. ADOV (2)
  • Angstrom Microsystems Inc. AGMS (46)
  • Apolo Gold and Energy Inc. APLL (1)
  • Apple Inc. AAPL (13)
  • Aquasil International Inc. AQUS (3)
  • Armco Metals Holdings Inc. AMCO (36)
  • AspenBio Pharma APPY (1)
  • Assured Pharmacy Inc. APHY (1)
  • Asta Funding Inc. ASFI (2)
  • Atlantic Energy Solutions Inc. AESO (1)
  • ATSI Communications Inc. ATSX (1)
  • Augme Technologies Inc. AUGT (70)
  • Auric Mining Corp. AUMY (3)
  • Automated Vending Technologies Inc. AVTC (3)
  • Automotive Company GNAU (11)
  • Avalon Oil and Gas Inc. AOGN (16)
  • Avant Diagnostics Inc. AVDX (29)
  • Avatar Systems Inc. AVSY (3)
  • Axiom Management Inc. AXMA (3)
  • Axis Technologies Inc. AXTG (2)
  • B2Digital Inc. BTOD (18)
  • Balatia Airlines BLTA (2)
  • Bald Eagle Energy Inc. BEEI (18)
  • Banjo & Matilda Inc. BANJ (8)
  • (4)
  • Beacon Enterprise Solutions Group BEAC (47)
  • Beacon Equity Research (552)
  • Beijing Med-Pharm Corp. BGJP (2)
  • Bergamo Acquisition Corp. BGMO (15)
  • Big Tree Group Inc. BIGG (36)
  • Bio-Clean International Inc. BCLE (1)
  • Bio-Matrix Scientific Group Inc. BMSN (1)
  • BioCentric Energy Holdings Inc. BEHL (1)
  • Biomagnetics Diagnostics Corp. BMGP (3)
  • bioMETRX Inc. BMRX (1)
  • Bionic Products Corp. BNPD (4)
  • Biophan Technologies Inc. BIPH (1)
  • BioSolar Inc. BSRC (22)
  • Biotech Holdings Ltd. BIOHF (3)
  • Inc. BZRT (9)
  • Black Diamond Brands Corp. BDMHF (1)
  • Blue Diamond Ventures Inc. BLDV (1)
  • Blue Water Global Group Inc. BLUU (7)
  • Blugrass Energy Inc. BLUG (4)
  • (1)
  • Boreal Water Collection Inc. BRWC (23)
  • Boston Therapeutics Inc. BTHE (20)
  • Bridgetech Holdings International Inc. BGTH (1)
  • Brighton Oil & Gas Inc. BROG (8)
  • Britannia Mining Inc. BMIN (14)
  • Brite Strike Tactical Illumination Products, Inc. BSTI (41)
  • Brookside Technology Holdings Corp BKSD (2)
  • Bullzi Security Inc. BLLZ (3)
  • BWI Holdings Inc. BWIH (165)
  • Cal-Bay International Inc. CBYI (6)
  • Callisto Pharmaceuticals, Inc. (1)
  • Calpian Inc. CLPI (27)
  • CAMAC Energy Inc. CAK (2)
  • Canam Energy Inc. CNGJ (10)
  • CanAm Uranium Corp. CAUI (58)
  • Cannabics Pharmaceuticals Inc. CNBX (14)
  • Capital City Energy Group Inc. CETG (18)
  • Car Monkeys Group CKMY (15)
  • Carbon Sciences Inc. CABN (21)
  • CardioVascular BioTherapeutics Inc. CVBT (5)
  • Cardium Therapeutics Inc. CXM (44)
  • Cascade Technologies Inc. CSDT (2)
  • Cascadia Investment Inc. CDIN (4)
  • Casey Corp. CCPR (1)
  • Cashcow Magazine (4)
  • Cavico Corp. CVIC (3)
  • CD International Enterprises Inc. CDII (23)
  • CDC Corp. CHINA (4)
  • CelebDirect Inc. CELI (3)
  • Cellceutix Corp. CTIX (18)
  • CellCyte Genetics Corp. CCYG (3)
  • Century Group, Inc. CEYG (1)
  • CEOcast (184)
  • CepTor Corp. CEPO (1)
  • Cereplast Inc. CERP (9)
  • Chancery Resources Inc. CCRY (3)
  • Changing Times Vitamins Inc. SGTB (12)
  • CHDT Corp. CHDO (5)
  • Cherubim Interests Inc. CHIT (36)
  • China 3C Group CHCG (13)
  • China America Holdings Inc. CAAH (8)
  • China Direct Inc. CDS (4)
  • China Education Alliance Inc. CEUA (4)
  • China Energy Recovery Inc. CGYV (12)
  • China Growth Development Inc. CGDI (2)
  • China Health Management Corp CNHC (7)
  • China Health Resource Inc. CHRI (14)
  • China INSOnline Corp. CHIO (1)
  • China Jiangsu Golden Horse Steel Ball Inc. CJGH (3)
  • China Logistics Group Inc. CHLO (11)
  • China Media Group Corp. CHMD (2)
  • China Medicine Corporation CHME (5)
  • China Nuvo Solar Energy Inc. CNUV (3)
  • China Organic Agriculture Inc. CNOA (11)
  • China Petroleum and Chemical Corp. SNP (2)
  • China Voice Holding Corp. CHVC (47)
  • China Wind Systems Inc. CWSI (6)
  • China Wireless Communications Inc. CWLC (4)
  • China Yongxin Pharmaceuticals Inc. CYXN (5)
  • China YouTV Corp. CYTV (1)
  • ChinaTel Group Inc. CHTL (1)
  • ChromaDex Corp. CDXC (3)
  • City Capital Corp. CTCC (2)
  • Cityside Tickets CIST (21)
  • CleanTech BioFuels Inc. CLTH (10)
  • Cleantech Transit Inc. CLNO (3)
  • Clearly Canadian Beverage Corp. CCBEF (13)
  • Cleartronic Inc. CLRI (52)
  • Clenergen Corp. CRGE (37)
  • CMG Holdings Inc. CMGO (2)
  • Coastal Integrated Services Inc. COLV (13)
  • Coil Tubing Technology Inc. CTBG (1)
  • Colorado Goldfields Inc. CGFI (5)
  • Colt Resources Inc. COLTF (13)
  • Columbia River Resources Inc. CRVR (1)
  • CoMedia Corp. CMTN (1)
  • CommercePlanet Inc. CPNE (4)
  • Compress Technologies Inc. CTLG (17)
  • Conforce International Inc. CFRI (2)
  • CAJT (9)
  • Cono Italiano Inc. CNOZ (12)
  • Consorteum Holdings, Inc. CSRH (160)
  • ContentChecked Holdings Inc. CNCK (60)
  • Continental Fuels Inc. CFUL (2)
  • Convergence Technology Group Inc. CNVC (7)
  • Copper King Mining Corp. CPRK (2)
  • Cord Blood America Inc. CBAI (102)
  • Crdentia Corp CRDT (12)
  • Creative Vistas Inc. CVAS (2)
  • Crystal International Travel Group Inc. CINT (4)
  • Cubic Energy Inc. QBC (2)
  • Cybermesh International Corp. CYTL (1)
  • Cyclone Power Technologies Inc. CYPW (9)
  • CYIOS Corp. CYIO (1)
  • Daily Views (13)
  • Dakshidin Corp. DKSC (5)
  • Data Call Technologies Inc. DCLT (25)
  • Daulton Capital Corp. DUCP (26)
  • Davi Skin Inc. DAVN (1)
  • Debt Resolve Inc. DRV (2)
  • Debut Broadcasting Corporation Inc. DBTB (1)
  • Deep Blue Marine Inc. DPBM (6)
  • Deep Down Inc. DPDW (15)
  • Deer Valley Corp. DVLY (2)
  • Defense Solutions Inc. DFSH (3)
  • Delta Mining and Exploration Corp. DMXC (1)
  • Dermisonics Inc. DMSI (1)
  • Destination Television Inc. DSTV (17)
  • Dhanoa Minerals Ltd. DHNA (4)
  • DigitalPost Interactive Inc. DGLP (8)
  • Document Capture Technologies Inc. DCMT (3)
  • DoMark International Inc. DOMK (29)
  • Dominovas Energy Corp. DNRG (68)
  • Dragon Capital Group Corp. DRGV (11)
  • Dragon International Group Corp. DRGG (2)
  • Duma Energy Corp. DUMA (20)
  • Duska Therapeutics Inc. DSKA (1)
  • Dutton Associates (88)
  • DXP Enterprises Inc. DXPE (4)
  • Dynamic Media Holdings Inc. DYMH (6)
  • Dynamic Response Group Inc. DRGP (6)
  • Dynasty Limousine Inc. DNYS (19)
  • Earth Dragon Resources Inc. EARH (10)
  • Eastbridge Investment Group Corp. EBIG (1)
  • Ebenefits Direct, Inc. EBFD (21)
  • eCareer Holdings Inc. ECHI (9)
  • Echo Therapeutics Inc. ECTE (5)
  • EcoloCap Solutions Inc. ECOS (2)
  • Ecologic Transportation Inc. EGCT (11)
  • Ecosciences Inc. ECEZ (1)
  • Ecotality, Inc. ECTY (67)
  • eCrypt Technologies Inc. ECRY (79)
  • EdgeTech International Inc. EGIL (6)
  • eDoorways Corp. EDWY (183)
  • Inc. EFSF (4)
  • EFuel EFN Corp. EFUL (1)
  • EGPI Firecreek Inc. EFIR (1)
  • Elephant Talk Communications Corp. ETAK (8)
  • Elephant Talk Communications Inc. ETAK (2)
  • Elleipsis Global Travel Solutions Inc. EGTS (3)
  • Elray Resources Inc. ELRA (11)
  • Elron Electronic Industries Ltd. ELRN (1)
  • Emerging Media Holdings Inc. EMDH (22)
  • Empire Energy Corporation International EEGC (3)
  • Endeavor Explorations Inc. EAVR (7)
  • Endeavour Silver Corp. EXK (3)
  • Endevco Inc. EDVC (2)
  • Energtek Inc. EGTK (61)
  • Enherent Corp. ENHT (2)
  • EnterConnect Inc. ECNI (5)
  • Enterprise Oilfield Group Inc. E.TO (13)
  • EnXnet Inc. EXNT (1)
  • Epazz Inc. EPAZ (22)
  • Equity Stock Analysis (1)
  • ER Urgent Care Holdings Inc. ERUC (6)
  • ERF Wireless Inc. ERFB (15)
  • Essential Innovations Technology Corp. ESIV (2)
  • Inc. ETLC (3)
  • Euoko Group Inc. EUOK (2)
  • EV Innovations Inc. EVII (189)
  • EV Transportation Inc. EVTP (7)
  • Exchange Media Corp. EXMD (9)
  • Exeter Resource Corp. XRA (2)
  • eXp World Holdings, Inc. EXPI (50)
  • Expert Group Inc. EXPT (5)
  • ExpressIR Inc. (1)
  • Extreme Motorsports of California, Inc. EMOC (26)
  • ezBanc-A Stocklender's Journal (6)
  • Falcon Crest Energy FCEN (75)
  • Falcon Ridge Development Inc. FCNR (2)
  • Famous Uncle Als Hot Dogs & Grille Inc FDOG (10)
  • Fastfunds Financial Corp. FFFC (17)
  • Financial Media Group, Inc. FNGP (26)
  • Financial Services Exchange FSE (1)
  • First Titan Corp. FTTN (45)
  • FlexWeek Inc. FXWK (11)
  • FluoroPharma Medical Inc. FPMI (46)
  • Foldera, Inc. FDRA (11)
  • Force Energy Corp. FORC (5)
  • FormCap Corp. FRMC (29)
  • Fortune Market Media Inc. FTMM (5)
  • Franklin Mining Inc. FMNJ (1)
  • Freedom Leaf Inc. FRLF (12)
  • Fresh Harvest Products Inc. FRHV (7)
  • Fresh Promise Foods Inc. FPFI (12)
  • Freshstart Properties Inc. FSPP (1)
  • FrogAds Inc. FROG (6)
  • Frozen Food Gift Group Inc. FROZ (5)
  •, Inc. FNDM (56)
  • Fushi Copperweld Inc. FSIN (2)
  • Galenfeha Inc. GLFH (28)
  • Gastar Exploration Ltd. GST (2)
  • Gemini Explorations Inc. GXPI (12)
  • Gen2media Corp. GTWO (2)
  • General Environmental Management Inc. GEVI (56)
  • General Metals Inc. GNMT (1)
  • General Steel Holdings Inc. GSI (3)
  • GeoBio Energy Inc. GBOE (1)
  • GeoEye Inc. GEOY (4)
  • GeoPharma Inc GORX (1)
  • Giggles N’ Hugs Inc. GIGL (90)
  • Global Alumina Corp. GLA.U (1)
  • Global General Technologies Inc. GLGT (1)
  • Global Payout Inc. GOHE (38)
  • Global Realty Development Corp. GRLY (10)
  • Global Resource Corporation GBRC (48)
  • Global Roaming Distribution Inc. GRDB (34)
  • GlobalWise Investments Inc. GWIV (129)
  • GNCC Capital Inc. GNCP (24)
  • Golden West Brewing Company Inc. GWBC (3)
  • GoldSpring Inc. GSPG (4)
  • Google, Inc. GOOG (8)
  • (1)
  • Grandview Gold Inc. GVGDF (2)
  • Gray Publishing & Media, Inc. GPMIJ (15)
  • Graystone Park Enterprises Inc. GPKE (7)
  • Great Plains Holdings Inc. GTPH (28)
  • Green Earth Technologies GETG (1)
  • Green Star Alternative Energy Inc. GSAE (2)
  • Green Star Products Inc. GSPI (2)
  • Green Technology Solutions Inc. (GTSO) (19)
  • Greenbelt Resources Corp. GRCO (1)
  • Greenchek Technology Inc. GCHK (18)
  • GreeneStone Healthcare Corp. GRST (2)
  • Greenstone Holdings Inc. GSHN (2)
  • GRILLiT Inc. GRLT (8)
  • Growblox Sciences Inc. GBLX (24)
  • GT Legend Automotive Holdings Inc. GTLA (2)
  • GTX Corp GTXO (49)
  • Gulf Western Petroleum Corp. GWPC (3)
  • GWS Technologies Inc. GWSC (4)
  • Halcyon Jets Holdings Inc. HJHO (15)
  • Halitron Inc. HAON (11)
  • Hanover Financial Services (17)
  • Harbin Electric Inc. HRBN (2)
  • Harvey Electronics Inc. HRVE (1)
  • Hasco Medical Inc. HASC (7)
  • Hathway Corp. HWYI (1)
  • HeadsUp Entertainment International Inc. HDUP (3)
  • Healthnostics Inc. HNSO (1)
  • HealthSonix Inc. HSXI (1)
  • HealthSport Inc. HSPO (14)
  • Heartland Inc. HTLG (1)
  • Heartland Oil and Gas Corp. HTOG (7)
  • Hemis Corporation HMSO (19)
  • Hemisphere Gold Inc. HPGI (1)
  • Hemp Inc. HEMP (25)
  • Hendrx Corp. HDRX (1)
  • Hi-Shear Technology Corp. HSR (3)
  • HII Technologies Inc. HIIT (8)
  • Holloman Energy Corp. HENC (2)
  • Holmes Osborne (6)
  • Hologic Inc. HOLX (4)
  • Home Shopping Latino Inc. HSPG (8)
  • Hong Kong Highpower Technology Inc. HPJ (2)
  • HotOTC (61)
  • HotStockChat (3)
  • HotStockMarket (HSM) (3)
  • HST Global Inc. HSTC (11)
  • Hunt Gold Corp. HGLC (32)
  • HWI Global Inc. HWIC (3)
  • Hydrogen Corp. HYDG (1)
  • i-Level Media Group Inc. ILVL (3)
  • i2 Telecom International Inc. ITUI (7)
  • iB3 Networks Inc. IBNW (1)
  • IceWEB Inc. IWEB (5)
  • ICP Solar Technologies Inc. ICPR (3)
  • IDGLOBAL Corp. IDGJ (2)
  • IDO Security Inc. IDOI (22)
  • IFAN Financial Inc. IFAN (34)
  • iGambit, Inc. IGMB (5)
  • Imaging3 Inc. IMGG (2)
  • ImaRx Therapeutics Inc. IMRX (2)
  • Immune Therapeutics Inc. IMUN (11)
  • Impact E-Solutions Corp. IESO (1)
  • Imperial Petroleum Inc. IPMN (10)
  • Inca Designs Inc. IDGI.PK (4)
  • Independent Film Development Corp. IFLM (1)
  • Index Oil and Gas Inc. IXOG.OB (5)
  • India Globalization Capital Inc. IGC (4)
  • Industrial Biotechnology Corp. IBOT (1)
  • Infinite Group Inc. IMCI (48)
  • Inform Worldwide Holdings, Inc. IWWI (27)
  • Intec LTD ICLJY (1)
  • IntegraMed America Inc INMD (1)
  • Intelecom Inc. IECM (3)
  • Intelimax Media Inc. IXMD (31)
  • Intelligent Highway Solutions Inc. IHSI (6)
  • Intercept Energy Services Inc. IESCF (7)
  • Interleukin Genetics Inc. ILI (1)
  • International Barrier Technology Inc IBTGF (1)
  • International Consolidated Companies Inc. INCC (2)
  • International Stem Cell Corp. ISCO (226)
  • Inventergy Global Inc. INVT (15)
  • Investor Village (8)
  • Investors Business Daily (4)
  • InvestorsProfs (1)
  • InvestSource (11)
  • IPOs (8)
  • IR Biosciences Holdings Inc IRBS (3)
  • Isonics Corp. ISON (1)
  • ItsAboutFinance (2)
  • JC Data Solutions Inc. JCDS (4)
  • Joytoto USA Inc. JYTO (14)
  • JZZ Technologies Inc. JZZI (3)
  • KAL Energy Inc. KALG (3)
  • Kallo Inc. KALO (43)
  • Kandi Technologies Corp. KNDI (3)
  • KCM Holding Corp. KCMH (3)
  • Kingslake Energy Inc. KGLJ (2)
  • Klondex Mines Ltd. KLNDF (1)
  • Knobias KNBS (5)
  • Kraig Biocraft Laboratories Inc. KBLB (88)
  • L&L International Holdings Inc. LLFH (2)
  • Laguna Blends Inc. LAGBF (53)
  • Lantis Laser Inc. LLSR (5)
  • Last Mile Logistics Group LMLG (4)
  • Latitude 360 Inc. LATX (21)
  • LD Holdings Inc. LDHL (14)
  • Legacy Holdings Inc. LGYH (1)
  • Legacy Ventures International Inc. LGYV (24)
  • Legend Media Inc. LEGE (4)
  • Lifespan Inc. LSPN (1)
  • Lime Energy Corp. LIME (3)
  • Lingo Media Corp. LMDCF (18)
  • Linkwell Corporation LWLL (4)
  • Liquor Group Wholesale Inc. LIQR (22)
  • Inc. LFLS (47)
  • LOGIC Devices Inc. LOGC (1)
  • Logility Inc. LGTY (1)
  • LoJack Corp LOJN (3)
  • Longhai Steel Inc. LGHS (10)
  • Lotus Pharmaceuticals Inc. LTUS (1)
  • Low Carbon Technologies (LWCTF) (3)
  • Lucas Energy, Inc. LEI (17)
  • Mabwe Minerals Inc. MBMI (56)
  • Macquarie Infrastructure Company MIC (5)
  • Maine and Maritime Corp. MMA (1)
  • Majic Wheels Corp. MJWL (6)
  • Makeup Inc. MAKU (2)
  • Mammoth Energy Group Inc. MMTE (5)
  • Mantra Venture Group Ltd. MVTG (10)
  • Mariner’s Choice International Inc. MCII (2)
  • Martin Nutraceuticals MNIU (11)
  • Material Technologies Inc. MTCH (44)
  • Max Media Group Inc. MXMI (9)
  • Max Sound Corp. MAXD (30)
  • MC Endeavors Inc. MSMY (2)
  • MedeFile International Inc. MDFI (46)
  • MediaG3 Inc. MDGC (1)
  • Medical Transcription Billing Corp. MTBC (5)
  • Medina International Holdings Inc. MIHI (3)
  • Medisafe 1 Technologies Corp. MFTH (3)
  • Medivisor Inc. MVSR (1)
  • Mega Media Group, Inc. MMDA (30)
  • MegaWest Energy Corporation MGWSF (2)
  • Memry Corp. MRY (2)
  • Metro One Development Inc. MODI (2)
  • Mexico Energy Corp. MXC (1)
  • Micro Identification Technologies Inc. MMTC (44)
  • MicrocapMoney (2)
  • Microsoft Corporation MSFT (4)
  • Midway Gold Corp. MDW (1)
  • Military Resale Group MYRL (19)
  • Minco Silver Corp. MSV.TO (1)
  • Mindpix Corp. MNDP (1)
  • MIP Solutions Inc. MSOL (7)
  • MIT Holding MITD (36)
  • MitoPharm Corp. MTPH (1)
  • Mizati Luxury Alloy Wheels, Inc. MZTI (14)
  • Mobile Entertainment Inc. MBEI (1)
  • Mobile Lads Corp. MOBO (43)
  • Momentous Entertainment Group Inc. MMEG (19)
  • Monaker Group Inc. MKGI (38)
  • Money4Gold Holdings Inc. MFGD (3)
  • Holdings Inc. MBKR (2)
  • Mosquito Consolidated Gold Mines Limited MSQ.V (1)
  • Moxian Inc. MOXC (55)
  • mPhase Technologies Inc. XDSL (12)
  • MSE Enviro-Tech Corp. MEVT (4)
  • Muscle Flex Inc. MFLI (55)
  • MusclePharm Corp. MSLP (23)
  • Mvive Inc. MVIV (22)
  • My Automated Advisor (4)
  • MyECheck Inc. MYEC (99)
  • Inc. MYST (1)
  • Nanogen Inc. NGEN (2)
  • Nanometrics Inc. NANO (1)
  • NanoSensors Inc. NNSR (1)
  • NanoTech Entertainment Inc. NTEK (30)
  • Napster, Inc. NAPS (5)
  • National Automation Services Inc. NASV (67)
  • National Coal Corp. NCOC (2)
  • Naturally Iowa Inc. NLIA (2)
  • NavStar Technologies Inc. NVSR (16)
  • nCoat Inc NCOA (8)
  • Neah Power Systems NPWZ (14)
  • Neohydro Technologies Corp. NHYT (4)
  • Neoprobe Corp. NEOP (6)
  • NeoStem Inc. NBS (6)
  • Net Element Inc. NETE (7)
  • NetSol Technologies Inc NTWK (64)
  • Neurobiological Technologies Inc. NTII (3)
  • NeuroMama Ltd. NERO (15)
  • Neutra Corp. NTRR (37)
  • New Asia Gold Corp. NWAG (1)
  • New Generation Biofuel Holdings Inc. GNB (3)
  • NewMarket China Inc. NMCH (7)
  • NewMarket Technology Inc. NMKT (7)
  • Newport Digital Technologies Inc. NPDT (61)
  • Nexia Holdings Inc. NXHD (51)
  • NexMed Inc. NEXM (8)
  • NeXplore Corp. NXPC (4)
  • Next One Interactive Inc. NXOI (7)
  • NextGen Bioscience Inc. NXGB (1)
  • NextPhase Wireless Inc. NPHS (1)
  • Nexus Enterprise Solutions Inc. NXES (30)
  • NF Energy Saving Corp. of America NFES (1)
  • Nhale Inc. NHLE (18)
  • Nilam Resources Inc. NILR (4)
  • Nitro Petroleum Inc. NTRO (5)
  • North Bay Resources Inc. NBRI (10)
  • NuTech Inc. NTCI (1)
  • Nutra Pharma Corp. NPHC (21)
  • NutraNomics Inc. NNRX (30)
  • NuVim Inc. NUVM (1)
  • NVIDIA Corp. NVDA (1)
  • NXGen Holdings Inc. NXGH (1)
  • Oakridge Global Energy Solutions Inc. OGES (63)
  • Obee's Franchise Systems Inc. OBFM (1)
  • OBJ Enterprises Inc. OBJE (27)
  • Odyne Corporation ODYC (15)
  • Omega Commercial Finance Corp. OCFN (2)
  • OmniaLuo Inc. OLUO (1)
  • Omnicity Corp. OMCY (26)
  • Omninet Media.Com, Inc. ONMC (5)
  • On The Go Healthcare Inc. MODI (13)
  • On the Move Systems Inc. OMVS (102)
  • Oncolin Therapeutics Inc. OCOL (1)
  • One World Holdings Inc. OWOO (61)
  • Ones to Watch (1,331)
  • Onstream Media Corp. ONSM (5)
  • Onteco Corp. ONTC (4)
  • Open Energy Corp. OEGY (4)
  • Optical Systems Inc. OPSY (2)
  • Oramed Pharmaceuticals Inc. ORMP (2)
  • Organic Alliance Inc. ORGC (2)
  • (82)
  • OtcStockExchange (5)
  • OurPet's Company OPCO (67)
  • OxySure Systems Inc. OXYS (23)
  • P2 Solar Inc. PTOS (24)
  • Pacific Gold Corp. PCFG (3)
  • Pamplona Picks (1)
  • Pan Global Corp. PGLO (82)
  • PanGenex Corp. PGCX (3)
  • Paramount Gold and Silver Corp. PZG (3)
  • Patient Access Solutions Inc. PASO (7)
  • Patriot Energy Corp. dba TelTeck Solutions Inc PGYC.PK (11)
  • Patriot Scientific Corp. PTSC (6)
  • Peace Arch Entertainment Group Inc. PAE (1)
  • Peoples Educational Holdings Inc. PEDH (2)
  • Perf Go Green Holdings Inc. PGOG (12)
  • Perfect Web Technologies, Inc PWBI (11)
  • Perfectenergy International Ltd. PFGY (1)
  • Performance Health Technologies Inc. PFMH (31)
  • Pet DRX Corp. VETS (1)
  • Petro Resources Corp. PRC (2)
  • PetroSun Inc. PSUD (41)
  • Phantom Fiber Corp. PHFB (2)
  • Pilot Financial Communications (3)
  • Pipex Pharmaceuticals Inc. PP (2)
  • PITOOEY! Inc. PTOO (14)
  • Planet Nutrition Inc. PNHL (4)
  • Platina Energy Group Inc. PLTG (8)
  • PlayBOX Inc. PYBX (5)
  • Players Network PNTV (4)
  • Pluristem Therapeutics Inc. PSTI (10)
  • Positron Corp. POSC (3)
  • Power of the Dream Ventures (1)
  • Power Play Development Corp. PWPY (17)
  • Powersafe Technology Corp. PWSF (1)
  • Premier Energy Corp. PNRC (1)
  • Pressure BioSciences Inc. PBIO (41)
  • PRG Group Inc. PRGJ (2)
  • PrimEdge Inc. PEDI (1)
  • Private Equity Securities (93)
  • Pro Motors Group Corp. PMGU (2)
  • Pro Travel Network Inc. PTVL (2)
  • ProGaming Platforms Corp. PPTF (22)
  • Proginet Corp. PRGF (3)
  • Prom Resources PRMO (9)
  • Propalms Inc. PRPM (3)
  • Provectus Pharmaceuticals Inc. PVCT (12)
  • Puget Technologies Inc. PUGE (23)
  • Pulmo BioTech Inc. PLMO (4)
  • Puramed Bioscience Inc. PMBS (3)
  • Pure Biofuels Corp. PBOF (4)
  • Pure H2O Inc. PURH (1)
  • Pure Hospitality Solutions Inc. PNOW (99)
  • Purio Inc. PURO (5)
  • Puritan Financial Group Inc. PTNG (1)
  • Purple Beverage Company Inc. PPBV (8)
  • QED Connect Inc. QEDC (4)
  • Qiao Xing Universal Telephone Inc. XING (2)
  • QPC Lasers Inc. QPCI (3)
  • Qualcomm Inc. QCOM (2)
  • QualityStocks for Women (16)
  • QualityStocks Partner StockGuru (3,878)
  • QualityStocks Stock Newsletter (550)
  • QualityStocks Stock Newsletters (18,166)
  • QualityStocks Video Charts (286)
  • Market Basics (6)
  • Quantum Fuel Systems Technologies Worldwide Inc. QTWW (15)
  • Quantum International Corp. QUAN (3)
  • Quasar Aerospace Industries Inc. QASP (6)
  • QuoteMedia Inc. QMCI (120)
  • Rafarma Pharmaceuticals Inc. RAFA (31)
  • Rainbow Coral Corp. RBCC (33)
  • Rancher Energy Corp. RNCH (9)
  • Raptor Resources Holdings Inc. RRHI (50)
  • Raven Gold Corp. RVNG (3)
  • Red Lake Exploration Inc. RLKX (19)
  • RegalWorks Media Inc. RWMI (4)
  • Regenicin, Inc. RGIN (6)
  • Reliant Financial Services Inc. RFNS (1)
  • Renhuang Pharmaceuticals Inc. RHGP (3)
  • ReoStar Energy Corp. REOS (1)
  • Resort Savers Inc. (RSSV) (10)
  • Revett Minerals (1)
  • Rock Energy Resources Inc. RCKE (4)
  • Rodman & Renshaw (432)
  • Ronn Motor Company Inc. RNNM (6)
  • Rox Resources Ltd. RXRS (3)
  • Royal Quantum Group, Inc. RYQG (10)
  • Royal Standard Minerals Inc. RYSMF (2)
  • Rudy Nutrition RUNU (27)
  • RXi Pharmaceuticals Corp. RXII (3)
  • Santa Fe Gold Corp. SFEG (5)
  • Santa Fe Holding Company SFHD (3)
  • Save The World Air Inc. ZERO (12)
  • Savoy Energy Corp. SNVP (26)
  • SavWatt USA, Inc. SAVW (5)
  • Seabridge Gold Inc. SA (1)
  • Seawright Holdings Inc. SWRI (1)
  • Sector 10 Inc. SECI (78)
  • SES Solar Inc. SESI (2)
  • Seven Arts Pictures plc SAPX (1)
  • Seven Arts Pictures PLC SAPXF (5)
  • Shazam Stocks (22)
  • ShotPak Inc. SHTP (35)
  • Shumate Industries SHMTE (1)
  • Sibling Group Holdings Inc. SIBE (55)
  • Sierra Gold Corp. SGCP (2)
  • Signature Devices Inc. SDVI (9)
  • Silver Dragon Resources Inc. SDRG (1)
  • Silver Falcon Mining Inc. SFMI (1)
  • SilverSun Technologies Inc. SSNT (30)
  • Simtrol Inc. SMRL (74)
  • Simulated Environment Concepts Inc. SMEV (130)
  • Singlepoint Inc. SING (33)
  • Sino Agro Food Inc. SIAF (1)
  • Sinobiomed Inc. SOBM (4)
  • Sinovac Biotech Ltd SVC (1)
  • Sipp Industries Inc. SIPC (2)
  • Skinny Nutritional Corp. SKNY (19)
  • Sky Petroleum Inc. SKPI (1)
  • SkyPostal Networks Inc. SKPN (66)
  • Small Cap Sentinel (2)
  • Small Cap Sleeper (3)
  • Smallcap Bullets (2)
  • (22)
  • SmallCapVoice (428)
  • Smoky Market Foods Inc. SMKY (9)
  • SocialPicks (1)
  • Sofame Technologies Inc SDW.V (1)
  • Sohm Inc. SHMN (14)
  • Solanex Management Inc. SLNX (15)
  • Solar Energy Initiatives Inc. SNRY (14)
  • Solar Wind Energy Tower Inc. SWET (15)
  • Solarfun Power Holdings Co. Ltd. SOLF (2)
  • Soul and Vibe Interactive Inc. SOUL (14)
  • South Sea Energy Corp. SSGY (7)
  • Soyo Group Inc SOYO (2)
  • SpaceDev Inc. SPDV (5)
  • Sparta Commercial Services Inc. SRCO (31)
  • Speedemissions Inc. SPMI (14)
  • Spicy Pickle Inc SPKL (18)
  • SpongeTech Delivery Systems Inc. SPNG (14)
  • Sports Pouch Beverage Company Inc. SPBV (1)
  • Star Mountain Resources Inc. SMRS (37)
  • Start Scientific Inc. STSC (22)
  • Stock Market E-News (1)
  • Stock Promoters (4)
  • StockEgg (14)
  • Stocks to Watch (1,756)
  • StocksJournal (2)
  • StockUPTicks (165)
  • Stockwire (6)
  • Strategic American Oil Corp SGCA (32)
  • Stratos Renewables Corp. SRNW (89)
  • StreamTrack Inc. STTK (31)
  • Striker Oil & Gas Inc. SOIS (4)
  • Sun Motor International Inc. SNMO (1)
  • SUN Sports & Entertainment Inc. SSPE (3)
  • Sunshine Biopharma Inc. SBFM (6)
  • Superlattice Power Inc. SLAT (60)
  • SupportSave Solutions, Inc. SSVE (10)
  • Surefect Holdings Inc. SUFH (1)
  • Suspect Detection Systems Inc. SDSS (37)
  • Sweet Success Enterprises Inc. SWTS (35)
  • Swiss Hawk AG SWHKF (1)
  • Symposium Production Corp. SYPJ (1)
  • Tactical Air Defense Services, Inc. TADF (15)
  • Tao Minerals Ltd. TAOL (1)
  • TapImmune Inc. TPIV (14)
  • Taplmmune Inc. TPIM (1)
  • Technology Applications International Inc. NUUU (25)
  • TechPrecision Corp. TPCS (4)
  • Tecton Corp. TTNC (3)
  • Teknik Digital Arts Inc. TKNK (10)
  • Telanetix Inc. TNXI (2)
  • Teletouch Communications Inc. TLLE (5)
  • Terax Energy Inc. TEXG (32)
  • Terme Bancorp TMEB (1)
  • Terra Nostra Resources Corp. TNRO (25)
  • The Amergence Group AMNG (8)
  • The Aristocrat Group Corp. ASCC (113)
  • The Bowser Report (68)
  • The Bull Report (32)
  • The Capital Report (5)
  • The DIRECTV Group Inc. DTV (1)
  • The Fight Zone Inc. TFZI (12)
  • The Guitammer Company Inc. GTMM (38)
  • The International Traders Expo (30)
  • The Mobile Star Corp. MBST (7)
  • The Motley Fool (3)
  • The Mundus Group Inc. MNDS (1)
  • The Penny Stock Blog (28)
  • The Principal Structure Fund, Inc. PSF (2)
  • The Tracking Corp. TRKG (1)
  • The UpTurn, Inc. UPTR (20)
  • The Wall Street Savant (24)
  • The Wide Angle (3)
  • Thresher Industries Inc. THRR (15)
  • Tidelands Oil and Gas Corp. TIDE (1)
  • Tiens Biotech Group USA Inc. TBV (1)
  • TMT Capital Corp. TMTP (1)
  • TNI BioTech Inc. TNIB (16)
  • Tombstone Exploration Corp. TMBXF (9)
  • TOMI Environmental Solutions Inc. TOMZ (4)
  • Tootie Pie Company, Inc. TOOT (11)
  • Torchlight Energy Resources, Inc. TRCH (2)
  • TradeShow Marketing Company Inc. TSHO (21)
  • TransWorldNews (4)
  • Tri-Star Holdings Inc. TSHL (31)
  • Trimax Corp. TMXN (31)
  • TripleCrownStocks (9)
  • True 2 Beauty Inc. TRTB (43)
  • TwinTrader (8)
  • TXP Corporation TXPO (1)
  • TZ Ltd. TZL.AX (1)
  • U.S. Mine Makers Inc. USMM (1)
  • uKarma Corporation UKMA (1)
  • Ultitek Ltd. UITK (21)
  • Unbridled Energy Corporation TSX-UNE (21)
  • Unico Inc. UNCO (3)
  • Universal Bioenergy Inc. UBRG (3)
  • Universal Detection Technology UNDT (41)
  • Universal Energy Corp. UVSE (19)
  • Universal Property Development and Acquisition UPDA (4)
  • Universal Tracking Solutions Inc. UTRK (13)
  • Universal Travel Group UTVG (14)
  • UpSNAP Inc. UPSN (1)
  • Uranium Energy Corp. UEC (64)
  • Uranium Hunter Corp. URHN (17)
  • Urex Energy Corp. URXE (1)
  • USA Recycling Industries Inc. USRI (21)
  • USA Superior Energy Inc. USSU (9)
  • Ustelematics Inc. UTLM (27)
  • Utah Uranium Corp. UTUC (2)
  • Utilicraft Aerospace Industries Inc. UITA (2)
  • ValueRich & iValueRich (9)
  • Vaporin Inc. VAPOD (2)
  • VentriPoint Diagnostics Ltd. VPTDF (26)
  • Vermillion Inc. VRML (3)
  • Vertical Branding Inc. VBDG (11)
  • VIASPACE, Inc. VSPC (185)
  • Victory Energy Corp. VYEY (29)
  • Vidshadow Inc. VSHD (1)
  • View Systems Inc. VSYM (16)
  • Viper Networks Inc. VPER (2)
  • Viral Genetics Inc. VRAL (3)
  • Viropro International Inc. VPRO (2)
  • VirTra Systems Inc. VTSI (22)
  • Viscount Systems Inc. VSYS (27)
  • visionGATEWAY Inc. VGWA (1)
  • VistaGen Therapeutics Inc. VSTA (104)
  • Visualant Inc. VSUL (5)
  • Vital Products Inc. VTLP (5)
  • Viyya Technologies Inc. VYON (2)
  • VizStar Inc VIZS (24)
  • Voiceserve Inc. VSRV (18)
  • Vortex Resources Corp. VTEX (7)
  • Vsurance Inc. VSUR (3)
  • Vyteris Inc. VYHN (1)
  • W2 Energy Inc. WWEN (13)
  • Wall Street News Alert (76)
  • WallStreetGrapevine (12)
  • WaterPure International Inc. WPUR (4)
  • Wave Systems Corp. WAVX (5)
  • Week in Review (2)
  • Well Power Inc. WPWR (77)
  • Wescorp Energy Inc. WSCE (18)
  • West Canyon Energy Corp. WCYO (1)
  • Western Standard Energy Corp. WSEG (7)
  • Who's Your Daddy Inc. WYDI (7)
  • WikiLoan Inc. WKLI (14)
  • Wind Energy America Inc. WNEA (3)
  • Wisdom Homes of America Inc. WOFA (15)
  • Wits Basin Precious Minerals Inc. WITM (2)
  • Woize International Ltd. WOIZ (1)
  • WordLogic Corp. WLGC (40)
  • Workstream Inc. WSTM (9)
  • WorldWater & Solar Technologies Corp. WWAT (10)
  • Worldwide Energy and Manufacturing WEMU (12)
  • Worldwide Manufacturing USA Inc. WWMU (6)
  • WRIT Media Group Inc. WRIT (36)
  • X-Change Corp. (XCHC) (2)
  • Xaar Plc XAARF (1)
  • Xenomics Inc. XNOM (1)
  • XsunX Inc. XSNX (17)
  • XZERES Corp. XPWR (2)
  • Younger America YNGR (13)
  • Zacks Investment Research (11)
  • ZAGG Inc. ZAGG (9)
  • Zaldiva Inc. ZLDV (3)
  • ZAP ZAAP (15)
  • ZBB Energy Corp ZBB (7)
  • Zenosense Inc. ZENO (53)
  • Zentric Inc. ZNTR (14)
  • Zevotek Inc. ZVTK (8)
  • Znomics Inc. ZNOM (3)
  • Newsletter Signup

    Stay ahead of the pack with QualityStocks and receive "The QualityStocks Daily", our summary formatted newsletter containing stock tips from hundreds of online investment newsletters.

    Rotate your device 90° to view site.
    133 medrol online buy epivir hbv in australia buy toprol xl via mail 20 evecare tablets brand viagra sin receta avon case study analysis essay where to buy camelot online vitamin c supplements cheapest dramamine online achat lamisil en ligne good questions start research paper acquista vigrx for men generico online where can i buy lasix buy online without dr approval geodon australia kamagra polo ohne rezept bestellen acquisto olzap italia avana buy online kamagra chewable refill from canada four sentence types 40 mg lopressor pills on line for sale best buy sildalis online without prescription 100mg fludac best price antabuse without prescriptions education is for all essay 200 mg os aricept in india brand rumalaya fort overnight shipping integra inc minneapolis mn 100mg penis growth patch reviews essays on themes acquistare imodium sicuro forum lesson plan on wordiness cleocin 300 mg power engineering research papers statement thesis write mcgraw hill 75 essays autobiography for college students write disagree agree essay sample job letter of recommendation safe buy lithobid no prescription active ingredient in viramune zebeta by mail from a us company buy discount seroquel online mellaril cheapest 10 mg sinte online overnight best essay writing uk best carpet for allergies indocin med 50 mg kamagra soft cheap 100mg alertec tablets vimax power coffee refill best price cheap viagra from india safe buy pamelor no prescription avandia side starlix nasl kullanlr brand cycrin online no prescription order discount cephalexin online ultimate male enhancer for sale generic grifulvin v no prescription is walmart good for america research paper serevent over the counter uk brand vpxl usa infant shots tylenol interferes fox news cleocin cream vaginal autobiography essay theoretical and critical comparative essay the columbian exchange voltarol purchase art gallery sales cover letter kafra apotheke breast success buy pharma Prograf no prescription needed college essays about lifetime goals book review example for middle school types of writing essay english essay topics class 12 paying for essays where to purchase roxythromycin no prescription free shipping essays assignments buy septilin with mastercard best price on phenamax phd thesis on retention of employees Suhagra usa bestellen cheap generic Suhagra - Daly City 200 mg glucotrol sale sale plavix reasonably priced without a prescription compare and contrast essay help 150 mg brahmi differin 20mg bestellen rezeptfrei cheap cardarone mail order without prescription plavix mexico where to buy trileptal online pay by visa resume how Floxin purchase online an essay on should mothers go to work buy ayurslim with mastercard fosamax sale silvo pharmacy cheapest combivir free shipping careprost online pharmacy what marriage means to me essay are generic evecare good buy decadron via mail best place to order generic benemid active ingredient in leukeran maxalt from mexico pharmacy online 100 mg glucotrol xl or 50 mg critical essay about the count of monte cristo freshers resume samples in word format how to write a diary book virility pills vp-rx for sale in australia 5 mg persantine canada thorazine quotes gibbs reflective practice essay buy cheap generic anacin txt speek sat essay losartan doses resume for college application front page thesis herpes beer pong kamagra tablets for sale cialis 5mg tablets price sale brand levitra without prescription achat de viagra plus en ligne micoflu 400 mg no percription gmu thesis template get viagra prescription without 25 mcg nortriptyline for sale health data analyst cover letter voltaren xr overnight discount cleocin gel online no membership free shipping xalatan 0.005% in europe buy generic antivert online 2.5 mg asacol generic 150mg pentasa buy online buy spanish fly online cheap germany discount symmetrel reasonably priced without a prescription essay on the movie a beautiful mind topics about technology for writing brand viagra outside the usa best buy sure romance reasonably priced without a prescription triamcinolone injections side effects allergies alfacip over the counter purchase eskalith cheap medication achat kamagra jelly pour la suisse worst day of my life essay scholarship award lamictal no prescription needed thesis electrical where can i order lukol no prescription free shipping delivery acquisto ultimate male enhancer con mastercard violence on television essay best price on virility pills vp-rx coupon advantages and disadvantages of internet short essay in english essays modernism art buying online klimacto-ritz cheap no script 500 mg amra cheapest expository essay with thesis statement minocin generika kaufen discount methotrexate no prescription free shipping delivery camelot 15mg price uk american noroxin distributors history of homosexuality as mental illness achat de super tadarise quebec nootrop-piracetam no perscription naproxen buy uk acheter trental sur lyon 64 essay tungkol kay kaibigan 40 mg geriforte pills on line for sale revatio outside the usa dma thesis help acheter atenoric livraison rapide beat generation essay thesis essay on why go lynoral se glucotrol dosis purinethol se brand Taicold Sachet overnight delivery Taicold Sachet generic drug - Gresham buy peo overnight shipping 250 mg toprol buy paypal discount viagra soft fruit canadian pharmacy resume for lawyers achat de generique trecator-sc purchase cheap generic atrovent buy loxitane for sale without a prescription purchase lisinocor h cheap medication 100mg phenamax for sale 150mg revia buy online cancer guide worldwide pamelor online free shipping buy benadryl generic paper cup buyers in dubai ed super advanced pack tablets write a good research paper how can i get zagam in extra super lovevitra where to buy buy female viagra generic 5000 word dissertation example white collar crime essay questions where to buy ayurslim buying without a prescription voveran sr patient assistance astelin dosis ketoconazole without insurance 1mg viagra brand name zoloft cheap thesis entrepreneurship